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Abstract 
Seshu Kumar Kaza 
Functional characterization of recombinant Kv1 channel 
subtypes in HEK-293 cells for screening of selective inhibitors 
Shaker-related voltage activated K+ channels or Kv1 channels occur in neurons as homo- 
and hetero-tetramers of α subunits (Kv1.1-1.7), associated with auxiliary β subunits, and 
control their excitability. The aim of this project was to create recombinantly homo- and 
hetero-meric Kv1 channel constructs resembling those in neurons, using a novel 
concatenation strategy, and to evaluate their expression and function in HEK-293 cells. 
This involved either altering the number and arrangement of each subunit or mutating their 
genes to change the sensitivities to tetraethylammonium (TEA) or other blockers. α subunit 
genes encoding Kv1.1, 1.2, 1.4 and 1.6 were amplified and concatenated with unique 
restriction enzymes for cassette cloning and sub-cloned in different combinations, 
generating homo- and hetero-tetramers of known composition to facilitate their expression 
as single proteins. Restriction enzyme digestion and DNA sequencing of extracted plasmid 
from E. coli transformed with the concatenated genes established that the tetramers have 
the correct integrity and composition. Biotinylation and Western blotting confirmed the 
expression of intact tetrameric channels on the surface of transfected HEK-293 cells. 
Repositioning of α Kv1.6 subunit in a hetero-tetramer revealed that N-type rapid 
inactivation, a characteristic feature of Kv1.4-containing channels, can be over-ridden by an 
adjacent Kv1.6 via the latter’s N-type inactivation prevention (NIP) domain. Mutation of 
critical residues in the NIP restored the fast inactivation in Kv1.4-containing channels. In 
another objective to understand and raise the TEA sensitivity of Kv1.1/1.2-containing 
hetero-tetrameric channels, increasing the ratio of Kv1.1 to 1.2 in a Kv1.2-1.2-1.1-1.2 or 
mutagenesis of the critical residue in the first Kv1.2, placed adjacent or in close proximity 
to a Kv1.1 subunit in Kv1.2-1.2-1.2-1.1, made the channels more sensitive to TEA. 
Additionally, increasing the number of Kv1.1 subunits in a tetrameric channel decreases the 
voltage threshold and accelerates the activation kinetics. Overall, these findings assessed 
the possible consequences of α subunits being precisely arranged in Kv1 channels, by 
examining recombinantly created variants with known composition, an important criterion 
in designing drugs selective for Kv1 oligomeric subtypes. Screening of small inhibitor 
compounds for Kv1.1 allowed us to identify 2,2’-((5,5’-(di-p-topyldipyrromethane)bis(2,2’-
carbonyl)bis(azanediyl))diethaneamine.2HCl as a potential therapeutic drug for use in the 
treatment of multiple sclerosis (MS). It potently (IC50 = ~15 µM) and selectively blocks 
Kv1.1 channels recombinantly expressed in mammalian cells. This novel inhibitor also 
induces a positive shift in the voltage-dependency of K+ current activation and slows the 
activation kinetics. Importantly, this new non-photo-toxic compound inhibited Kv1 
heteromeric channels containing 2 or more Kv1.1 subunits, regardless of their positioning in 
concatenated tetramers, though Kv1.3-mediated K+ current was reduced to a lesser extent. 
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CHAPTER 1 
 
GENERAL INTRODUCTION 
 
1.1 Ion channels 
The cell membrane, a bilayer of phospholipids containing hydrophobic fatty acid tails 
facing each other in the middle of the bilayer, is normally impermeable to all but small, 
uncharged molecules. In order to allow important physiological ions to cross this barrier, 
ion channels serve as highly selective filters through which ions can pass into and out of 
cells. These are integral membrane proteins present in both excitable and non-excitable 
cells. In response to alterations in intracellular pH, concentration of ions, or membrane 
voltage some parts of the ion channel proteins change their conformation, thereby, opening 
or closing their conduction pore (Hille, 2001). With over 400 members of ion channels 
identified in the human genome, voltage- and ligand-gated ion channels are widely studied 
functional groups of proteins in heterologous expression systems (Klassen et al., 2011). 
Propelled by electrochemical gradients, these channels allow passive passage of small ions 
across the lipid membrane. Membrane excitability is a characteristic of many cell types in 
all animals. For example, channels can gate open and close an ion conduction pathway in 
response to the changes in membrane potential, neurotransmitter or other chemical 
stimulus, so as to modulate neuron excitability (Hille, 2001). The movement of ions, 
mainly, potassium ion (K+), sodium ion (Na+), calcium ions (Ca2+) and chloride ion (Cl-), 
through their respective ion channels are responsible for the shaping of action potential 
(AP) (Lockery and Goodman 2009). K+ channels are the primary determinants of the 
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resting membrane potential of the cell and the major modulators of the shape, duration, 
frequency and repolarization phase of APs in excitable cells (Kuo et al., 2005; Stein and 
Litman, 2015).  
 
1.2 K+ channels 
K+ channels are the most diverse group of proteins that have been observed, being present 
in virtually all cell types from a wide phylogenetic range of species, including prokaryotes 
(Milkman, 1994). The first K+ channel gene was cloned from the Drosophila Shaker locus 
(Papazian et al., 1987). Based on the structural and functional diversity, observed from 
molecular cloning and functional expression studies, K+ channel genes were grouped into 
several conserved families. However, all K+ channel genes share a universal feature of 
having a hyper-conserved signature sequence that forms a part of a K+-selective pore 
(Heginbotham, et al. 1992, 1994) and have three basic properties: 1) high conduction rates 
upto 107 - 108 ions per second, 2) selectivity for K+ and 3) their conduction is gated (Doyle 
et al., 1998). They are involved in performing basic and specific cellular functions, such as 
setting of resting potentials and defining the inter-spike intervals of endogenously beating 
cells, respectively (Bezanilla, 2008). K+ channels are encoded by 30-100 different K+ genes 
in humans, Drosophila, and Caenorhabditis elegans (Miller, 2000; Heitzmann and Warth, 
2008). 
1.3 Classification of K+ channels into families based on the structure of 
their transmembrane segments 
Cloning followed by physiological, functional and structural analysis of K+ channels has 
allowed their classification into different families characterized by the number of 
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transmembrane (TM) segments and pore (P) domains (Fig 1.1). Inward rectified channels 
(Kir channels) have 2TM segments with 1P domain; tandem two pore-domain (K2P) 
channels comprise 4TM segments and 2P domains; voltage-gated channels contain 6TM 
segments plus 1P domain. The yeast Tok1 K+ channel has 8TM segments (Pongs, 1992; 
Wei et al., 1996; Jan and Jan, 1997; Talley et al., 2003; Buckingham et al., 2005).  
 
 
 
Fig.  1.1 Schematic of transmembrane (TM) segments and pore-forming (P) domains of the three main 
classes of K+ channels.  
(a) Inward rectifier channels, which contain two TM domains and one P domain; (b) Two-
pore-domain channels, which contain four TM domains and two P domains and (c) 
Voltage-gated K+ channels, which contain six TM domains and one P domain (adapted 
from Buckingham et al., 2005). 
 
The ancestor of the K+ channel types is thought to be the 2TM K+ channel based on its wide 
distribution in both prokaryotes and eukaryotes. Addition of other transmembrane segments 
to the N-terminus of a 2TM precursor could have yielded other families of K+ channel 
proteins such as 4TM and 6TM K+ subtypes, with distinguished features from the primitive 
ones (2TM channels). For instance, 6TM channels have intrinsic gating structures as 
opposed to the Kir inward rectifiers, which are gated by extrinsic cytoplasmic factors, Mg2+ 
and/or polyamines (Lopatin et al., 1994). Voltage-gated Ca2+ and Na2+ channels, which 
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belong to 6TM channels, probably originated from their ancestral tetrameric 6TM K+ 
channel (Gutman et al., 2003, 2005). 
 
1.4 Nomenclature and families of voltage-gated potassium (Kv) channels 
The voltage-gated K+ channels (Kv) play an important role in determining the electrical 
properties of excitable cells. In response to membrane depolarization, Kv channels allow 
increased K+ efflux from cells and attain resting potential when hyperpolarized (Huang and 
Jan, 2014). Studies revealed the involvement of multiple Kv channels in controlling the 
process of falling phase of the AP in excitable cells (Jan and Jan, 1990). In addition to their 
vital role in excitable cells, Kv channels expressed in non-excitable cell types also have an 
essential role in various functions including electrolyte transport, cell volume regulation, 
cell migration, wound healing, proliferation, apoptosis, carcinogenesis, and oxygen sensing 
(O’Grady et al, 2005) in tissues such as renal (Hebert et al, 2005), gastro-intestinal 
(Hietzmann and Warth, 2008) and respiratory epithelia (Bardou et al, 2009). Voltage-
sensitivity of Kv channels is provided by positively charged amino acids (lysine or arginine) 
in S4 transmembrane region and a tripeptide sequence motif located in P-loop of the S5-S6 
linker represents the K+ selectivity filter of the pore (Shieh et al., 2000).  
 
Alignment and analysis of amino acid sequence in hydrophobic cores (S1–S6) of human Kv 
channels revealed the phylogeny tree of Kv channels (Kv1-9 families) comprising of Kv1-6 
and Kv8-9 families. Gutman et al. updated the existing tree by incorporating the sequences 
of Kv7.1–7.5, Kv6.4, and Kv8.2 to the existing alignment, by use of a combination of 
maximum parsimony and neighbor-joining analysis (Gutman et al., 2005; Stein and 
Litman, 2015). 
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Table 1.1 Classification and nomenclature of 6TM 1P K+ channels 
IUPHAR: International Union of Pharmacology; HGNC: Human Genome Organization (HUGO) 
Gene Nomenclature Committee (Gutman et al., 2005). 
Structural 
Class 
Families Subfamilies Members 
   IUPHAR HGNC 
6TM 1P Voltage-gated Shaker-related Kv1.1 KCNA1 
   Kv1.2 KCNA2 
   Kv1.3 KCNA3 
   Kv1.4 KCNA4 
   Kv1.5 KCNA5 
   Kv1.6 KCNA6 
   Kv1.7 KCNA7 
   Kv1.8 KCNA10 
  Shab-related Kv2.1 KCNB1 
   Kv2.2 KCNB2 
  Shaw-related Kv3.1 KCNC1 
   Kv3.2 KCNC2 
   Kv3.3 KCNC3 
   Kv3.4 KCNC4 
  Shal-related Kv4.1 KCND1 
   Kv4.2 KCND2 
   Kv4.3 KCND3 
  Modifier Kv5.1 KCNF1 
  Modifiers Kv6.1 KCNG1 
   Kv6.2 KCNG2 
   Kv6.3 KCNG3 
   Kv6.4 KCNG4 
 KQT KVLQT Kv7.1 KCNQ1 
  KQT2 Kv7.2 KCNQ2 
   Kv7.3 KCNQ3 
   Kv7.4 KCNQ4 
   Kv7.5 KCNQ5 
  Modifiers Kv8.1 KCNV1 
   Kv8.2 KCNV2 
  Modifiers Kv9.1 KCNS1 
   Kv9.2 KCNS2 
   Kv9.3 KCNS3 
 Eag eag1 Kv10.1 KCNH1 
  eag2 Kv10.2 KCNH5 
  erg1 Kv11.1 KCNH2 
  erg2 Kv11.2 KCNH6 
  erg3 Kv11.3 KCNH7 
  elk1, elk3 Kv12.1 KCNH8 
  elk2 Kv12.2 KCNH3 
  elk1 Kv12.3 KCNH4 
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Four conserved subfamilies, first cloned from Drosophila, comprise the Kv family of 
channels: Shaker (Papazian et al., 1987; Kamb et al., 1987; Pongs et al, 1988), Shab, Shaw 
and Shal (Wei et al., 1990) (Table 1.1). Extensive numbers of vertebrate homologies for 
each subfamily have been isolated (Chandy and Gutman, 1995). Only after the expression 
of Shaker in Xenopus oocytes and physiological studies was it possible to confirm that 
these proteins were really K+ channels (Tempel et al. 1987, 1988; Iverson et al., 1988; 
Papazian et al., 1988; Timpe et al., 1988). The Shaker locus has a large open reading frame 
of 21 exons that can produce several transcripts by alternative splicing (Papazian et al., 
1987; Tempel et al., 1987; Iverson et al., 1988). Using Shaker cDNA as a probe, it was 
possible to identify a K+ channel from rat brain, RCK1 (Baumann et al., 1988) and RBK1 
(Christie et al., 1989), and some inward rectifying channels (Kubo et al., 1993). 
Subsequently, the RCK1 sequence was used to probe cDNA libraries and led to the 
isolation of several more neuronal voltage-dependent K+ channel clones (Stuhmer et al., 
1988). At the same time, 3 additional voltage-dependent K+ channel members (Shab, Shal 
and Shaw) were identified in Drosophila by cross-hybridisation with the Shaker sequence 
(Covarrubias et al., 1991). As for Shaker, equivalents of these channels were also found in 
mammalian cDNA libraries; their K+ channel subunits are encoded by multiple separate 
genes whereas in Drosophila alternative splicing of a large transcriptional unit occurs. 
 
1.5 Shaker subfamily of Kv channels (Kv1)  
Shaker-related Kv1 subfamily is the most intensely studied among the diverse family of 
membrane-spanning proteins, Kv channels (Pongs and Schwarz, 2010). Involvement in 
controlling cell excitability and synaptic transmission make them potential targets for 
neurotherapeutics. Malfunctioning of Shaker subfamily members is involved in certain 
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human diseases (Kullmann, 2002) where they are altered by mutation (e.g. certain forms of 
epilepsy) or truncation (e.g. Episodic ataxia type I). In the healthy nervous system, Kv1 
channels are clustered in high density at, for example (1) the basket cell terminals (BCTs) 
of cerebellar pinceau where they regulate GABAergic inhibition of the Purkinje neuron 
efferent axon (McNamara et al., 1993), (2) juxta-paranodes of myelinated axons where they 
modulate AP propagation and dampen repetitive firing of injured and developing 
myelinated axons, and (3) axon initial segments (AIS) where they regulate AP waveform, 
synaptic efficacy, and threshold of cortical inter-neurons (Wang et al., 1993; Devaux et al., 
2002; Kole et al., 2007; Goldberg et al., 2008).  
 
1.6 α and β subunits of Kv1 channels 
The cloning and functional characterization of K+ channels from animals has revealed that 
K+ channels are formed by a hetero-oligomeric assembly of α- and β-subunits (Fig. 1.2) 
(Rehm and Lazdunski, 1988; Parcej and Dolly, 1989; Parcej et al., 1992; Rettig et al., 1994; 
Scott et al., 1994a; Orlova et al., 2003), of which α-subunits form the K+ channel (Jan and 
Jan, 1994). Although α subunits can form functional Kv channels alone, crystallographic 
and functional studies of β subunits conferred additional properties that match natural 
preparations. Auxiliary β subunits further contribute to the diversity of Kv channels as they 
co-assemble with α subunits and regulate both biophysical properties and channel 
trafficking to the membrane. In Kv1 channels, the structure of the highly conserved 
cytoplasmic N-terminal tetramerization domain or T1 domain (Fig. 1.2) of α subunit plays 
an important role in restricting Kv channel subunit hetero-multimerization in complex with 
an auxiliary β-subunit protein (Gulbis et al., 2000; Strang et al., 2001).  
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Fig. 1.2 Schematic of octomer Kv1 channel 3D structure.  
(a) Super-imposed semi-transparent K+ channel picture resulting from a X-ray structures of 
recombinant truncated KcsA (pink), T1 (red) and tβ2 tetramers (gold) before and after 
fitting into the electron microscopy (EM) map (blue); putative position of the 
triosephosphate isomerase (TIM) barrels are indicated with broken lines; approximate 
positions of N termini in tβ2 protein is depicted with stars along with red diamonds placed 
at its active sites. (b) Kv1 channel incorporated into a membrane, green stars identify the C 
termini of the (T1)4, adjacent to the connectors (blue arrows). The blue contours outline the 
extra mass visualized by EM near the N termini but absent from the X-ray map of (tβ2)4. 
The blue broken line (in figure on right, above the star) indicates the postulated position for 
the N-terminal extension in β1, containing the inactivation ball and chain, with a possible 
pathway to reach the inner mouth of the channel (adapted from Orlova et al., 2003). 
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In addition, the gating of the K+ channel is affected by the conformational changes in the 
buried polar interface between T1 subunits. The β2-subunit (or rather the truncated β2-
subunit, tβ2, with residues 1–35 omitted) showing a tetramer of oxidoreductase proteins 
with 4-fold symmetry (Fig. 1.2). Each of these subunits contains an active site with 
catalytic residues and a nicotinamide adenine dinucleotide phosphate cofactor. The 
complex of tβ2 with T1 demonstrated that T1 provides a docking platform for the auxiliary 
β-subunit whose activity is coupled to the channel's function (Orlova et al., 2003). 
 
Cloned Kvβ subunit genes from brain (Rettig et al., 1994; Scott et al., 1994b; Heinemann et 
al., 1995; Coleman et al., 1999) and heart (England et al., 1995; Majumder et al., 1995; 
Morales et al., 1995) encode cytoplasmic proteins that form stable complexes with Kv1α 
subunits and exert multiple effects on Kv1α currents. The Kvβ isoforms (three Kvβ1 
isoforms and Kvβ3) affects the inactivation kinetics to Kv1α subunits but with variable 
potency (Rettig et al., 1994; Heinemann et al., 1995; Wang et al., 1996). Complexes 
between Kv1α and Kvβ subunits have been found to form in the endoplasmic reticulum to 
assist the folding and assembly of the Kv1α subunits. The association of Kv1.2 with Kvβ 
subunits produces more efficient glycosylation of Kv1.2, by increasing the stability of Kv1.2 
through Kv1.2-Kvβ complex formation and results in an increase in cell surface expression 
(Shi et al., 1996; Nagaya and Papazian, 1997). Members of the same Kv family co-assemble 
in a homo- or hetero-terameric manner to form functional channels (Shamotienko et al., 
1997; Coleman et al., 1999). Kv1.4 co-localizes with Kv1.2 at juxta-paranodes and axon 
initial segments (Rasband et al., 2001; Ogawa et al., 2008), has the same PDZ [post 
synaptic density protein 95 (PSD95), Drosophila disc large tumor suppressor 1 (Dlg1), and 
zonula occluden-1 (ZO-1)] -binding motif as Kv1.2, and express more efficiently on the cell 
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surface than Kv1.2 because of the variation in a cytoplasmic C-terminal endoplasmic 
reticulum-export motif (Manganas et al., 2001a). 
 
In addition to the effect of co-assembled β subunits, the localization, expression and 
function of Kv1 channels is also influenced by other scaffolding proteins and enzymes 
(Schulte et al., 2006). Kv1 channels form macromolecular protein complexes with the cell 
adhesion molecules (CAMs) Caspr2 and TAG-1, the membrane-associated guanylate 
kinases (MAGUKs) PSD-93 and PSD-95, and the cytoskeletal scaffold (Poliak et al., 1999, 
2001; Traka et al., 2002; Horresh et al., 2008) though at BCTs neither Caspr2 nor PSD-95 
is needed for channel clustering (Rasband et al., 2002). Juxta-paranodal Kv1 channel 
clustering depends on CAMs, but not MAGUKs (Rasband et al., 2002; Poliak et al., 2003; 
Traka et al., 2003; Horresh et al., 2008). In contrast, Kv1 channel clustering at the AIS was 
reported to depend on MAGUKs rather than CAMs (Ogawa et al., 2008). Thus, although 
these different axonal domains share a similar molecular organization, their mechanisms of 
assembly are distinct. 
 
1.7 The pore-forming region of Kv channels 
A bacterial K+ channel from Streptomyces lividans, KcsA, was the first ion channel whose 
structure was determined (Doyle et al., 1998). It was identified as one of the channels of the 
inward rectified channels (Kir channels), although the pore region is more homologous to 
mammalian voltage-dependent channels. The crystallographic structure (Fig. 1.3) revealed 
considerable information on the pore region, selectivity filter (Doyle et al., 1998; Zhou et 
al., 2001) and ion conduction (MacKinnon, 2004). Studies based on molecular cloning and 
mutagenesis experiments have revealed that all K+ channels contain a conserved amino acid 
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region, called the pore region, composed of the sequence GYG. Mutation of single amino 
acid alters the channel activity, which is no longer able to discriminate between K+ and Na+ 
(Doyle et al., 1998).   
 
 
Fig. 1.3 Topology of Kv channels.  
(A) Schematic of the 6TM-1P topology of a Kv channel α-subunit with both amino (NH2) and 
carboxyl (COOH) terminus located intracellular. The S1–S4 segments form the voltage-sensing 
domain (VSD) (represented in gray) and the S5-P-loop-S6 region assembles with three other pore 
domains into the K+ permeation pathway. (B) Top view (from the extracellular side) of the 3D 
structure of the Kv1.2 channel (protein data bank accession code 2A79; Long et al., 2005). To 
illustrate the four-fold symmetrical assembly of the α-subunits into a functional channel, one α-
subunit is represented in red. In the other subunits the pore region (S5-P-loop-S6) is colored blue 
and the VSD (S1–S4) is represented in gray. Note that the pore regions form a centrally located K+ 
pore that is surrounded by four independent VSDs. (C) Side view of the pore module of the 2TM-
1P K channel KcsA that was crystallized in the closed state (protein data bank accession code 1BL8; 
adapted from Doyle et al., 1998). 
 
The first TM segment (Fig. 1.3a), M1 resembles S5 in Kv channels is located at the 
periphery and faces the lipid bilayer whereas the second (M2 corresponding to S6) forms 
the inner pore helix. The front and back α-subunit are omitted to illustrate the layout of the 
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K+ permeation pathway that - from the intracellular to the extracellular side - can be 
divided in three recognizable sections (Fig.1.3C); (1) a water filled inner tunnel, (2) a wider 
12Å diameter water filled cavity, and (3) a narrower outer tunnel that forms the ion 
selectivity filter (SF) that dictates K+ selectivity. Both the inner tunnel and the central 
cavity are formed by the inner pore helices that cross the membrane at an angle of ∼25° 
resembling an inverted teepee (Doyle et al., 1998). The K+ pathway contains two energy 
barriers for K+ that function as a gate: (1) at the bundle crossing (BC) of the M2/S6 helices 
(BC gate) that forms a barrier for hydrated K+ and (2) the SF that allows passage of K+ 
which have shed their hydration shell (Labro and Snyders, 2012). 
 
1.8 Molecular determinants of Kv channel function 
Besides being divided into subfamilies based on sequence homologies, Kv channels can be 
classified according to their biophysical behavior (Hille, 2001). Kv channels are all 
activated by depolarization, but present with wide diversity of activation and inactivation 
kinetics. 
1.8.1 Gating of Kv channels. As each α subunit contributes distinct properties, the resultant 
channels reaching the plasmalemma vary considerably in their pharmacological and 
biophysical properties. Kv1.4 is the only Kv1 member that shows both N- and C-type 
inactivation, yielding a distinctive A-type transient outward current (Stuhmer et al., 1989).  
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Fig. 1.4 Gating modes and models.  
Schematic cartoon of the conformational states and voltage-driven gating modifications of Kv 
channels. The drawings at the bottom represent two α-subunits and a symbolic cytoplasmic gate, 
with one diffusible ball-and-chain structure attached to their cytoplasmic face. N-type inactivation 
is a consequence of plugging of the pore after opening the cytoplasmic activation gate, and C-type 
inactivation by collapsing of the selectivity filter gate, are represented on the right (adapted from 
Barros et al., 2012). 
 
After opening of these Kv1 channels by membrane depolarization, inactivation follows via 
two mechanisms. N-type inactivation mediated through the N-terminal inactivation ball 
(NIB) occurs by a ‘ball and chain’ process in which NIB occludes the inner mouth of the 
ion pore (Hoshi et al., 1990; Zagotta et al., 1990) (Fig. 1.4). Mutations which affect N-type 
inactivation (Isacoff et al., 1991) and co-expression of Kv1.6 containing N-type inactivation 
prevention (NIP) influence channel conductance (Roeper et al., 1998). In addition, Kvβ1 
subunits provide alternative N-terminal domains that confer rapid inactivation on non- or 
slow-inactivating Kv1 channels. This is because Kvβ1 subunits contain an inactivation ball 
in the amino-terminal sequence that blocks the internal mouth of associated slow-
inactivating α subunits upon depolarization and leads to the formation of A-type Kv 
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channels (Rettig et al., 1994; Heinemann et al., 1996; Morales et al., 1996). On the other 
hand, C-type inactivation arises from prolonged depolarization which leads to a local 
rearrangement and constriction of the channel at the outer mouth (Yellen et al., 1994; Liu et 
al., 1996; Kiss and Korn, 1998). 
 
1.9 Native combinations of Kv1 channels in brain  
The extensive diversity in Kv currents is matched by the multiplicity of genes encoding the 
pore-forming or α-subunit of Kv channels (Jan and Jan, 1990). Each K+ channel α subunit 
gene encodes a single polypeptide, and functional channels are formed by the tetrameric 
association of individual subunits apparently mediated by specific binding between the N-
terminal domains of subunits within individual subfamilies (Li et al., 1992; Xu et al., 1995). 
Multiple copies of different Kv1 channel α subunit genes may co-assemble as heteromeric 
complexes (Wang et al., 1993; Shamotienko et al., 1997; Coleman et al., 1999) that are 
thought to form functionally distinct K+ channels. 
 
Kv1 channels in the brain, purified using the selective blockers α DTX (α dendrotoxin) or 
DTXk, are large (molecular mass ∼400 K) sialoglycoprotein (a combination of sialic acid 
and glycoprotein) complexes (Parcej et al., 1992) consisting of four pore-forming α 
subunits and four cytoplasmically-associated auxiliary β proteins (Scott et al., 1994a, b). 
When heterologously expressed alone, each of the major genes encoding α subunits 
[Kv1.1–1.6 (Stuhmer et al., 1989; Grupe et al., 1990; Swanson et al., 1990) and Kv1.7 
(Kalman et al., 1998)] yields a homo-tetrameric channel with distinct biophysical and 
pharmacological profiles. Heteromerized Kvl.4 and l.2 subunits have been localized in 
axons and nerve terminals, which may form the molecular basis of a presynaptic A-type K+ 
31 
 
channel involved in the regulation of neurotransmitter release (Sheng et al., 1993). Further 
diversity in vivo results from hetero-polymerization, but only a subset of the possible 
oligomeric combinations has been found in mammalian brain (Covarrubias et al., 1991; 
Shamotienko et al., 1997; Coleman et al., 1999; Sokolov et al., 2007), suggesting that their 
synthesis and/or assembly are restricted to members of the same family but not between 
subunits among different subfamilies (Kv1, 2, 3, or 4).  
 
Kv1.2 is the most prevalent in neuronal membranes where some occur as a homo-tetramer 
and the majority is heteromerized with other Kv1α subunits (Shamotienko et al., 1997; 
Coleman et al., 1999; Sokolov et al., 2007); interestingly, there is preponderance in these 
preparations of the less abundant Kv1.1 subunit in oligomers with Kv1.2. Following 
depolarization, the voltage-dependent delayed rectifier members of the Kv1 channel family 
play an important role in rapidly restoring the neuronal resting membrane potential. Both 
Kv1.1 and Kv1.2 heteromeric channels are considered low-voltage activated channels that 
open with small depolarizations below the resting potential (Brew et al., 2003 and 2007). 
Notably, the homomeric Kv1.1 channel activates at more negative potentials compared with 
its Kv1.2 counterpart when expressed in mammalian (Grissmer et al., 1994) or Xenopus 
(Akhtar et al., 2002) systems. This difference in their voltage-dependence of activation 
would confer rapid conduction of high-frequency APs (Wang et al., 1993; Wang et al., 
1995).  
 
1.10 Kv1 channelopathies 
Mutations or diseases that disrupt the clustering, localization, or composition of Kv1 
channels severely compromise nervous system function and lead to conduction block, 
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episodic ataxia, and/or epilepsies (Rasband et al., 1998; Eunson et al., 2000; Nashmi et al., 
2000; Manganas et al., 2001b).  Fergestad et al. reported that mutations affecting K+ and 
Na+ channel genes either by increase in membrane excitability or those that decrease 
membrane excitability can cause neuro-degeneration to varying degrees (Fergestad et al., 
2006). Abnormal Kv1.1 activity, originating in the distal motor axons, results in muscle 
hyperactivity, indicative for myokymia (da Silva et al., 1977; Newsom-Davis and Mills, 
1993). In addition to the classical description of this disorder, phenotypic variants include 
EA1 with partial epilepsy, isolated neuromyotonia (Zuberi et al., 1999; Eunson et al., 2000) 
and EA1 without myokymia (Lee et al., 2004). An electrophysiological study also revealed 
that a mutation (Kv1.1 N255D) in wild-type Kv1.1 results in a non-functional Kv1.1 channel 
(Glaudemans et al., 2009).  
 
1.10.1 Kv1 channels in multiple sclerosis (MS). Multiple Sclerosis (MS) is on the increase, 
being more common in young adults but also found in children. Prevalence of the disease 
ranges between 2–2.5 million worldwide (Milo and Kahana, 2010). According to the 
national incidence study in Ireland, there are over 8000 MS sufferers (The Multiple 
Sclerosis Society of Ireland, website listed in references). It is an inflammatory, neuronal 
demyelinating disease, with phenotypic neurological signs and symptoms ranging from 
vision impairment to movement disabilities (Pugliatti et al., 2006). The pathophysiology of 
demyelinated axons depends mainly on the re-distribution of Kv channels along the axon 
(Waxman, 1992), and the expression of unique subfamily member (Kv1) on demyelinated 
axons in patients suffering from MS contributes to abnormal propagation of nerve signals 
with resultant debilitating muscle weakness (Judge and Bever Jr., 2006). Selective 
inhibitors for this particular Kv1 channel associated with MS might well restore the 
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excitability of demyelinated axons, which appears to underlie clinical remissions in MS 
patients. Two K+ channel blockers, 4-aminopyridine (4-AP) and 3,4-diaminopyridine, are 
of some benefit in the symptomatic treatment of patients with MS (Bever, 1994;  Solari et 
al., 2002) by overcoming conduction block in demyelinated axons in MS lesions. Because 
of poor selectivity and indiscriminate blockade of other K+ channels present in neurons, 
these exert toxic side-effects. Thus, it is essential to identify new blockers which would 
have the potency and specificity to inhibit only the MS-associated Kv1channel subtype.  
 
1.11 Pharmacology of Kv1 channels  
1.11.1 Small blockers of Kv1 channels. The two primary criteria for delayed rectifier Kv 
channel classification are that they are both 4-AP sensitive or insensitive and 
tetraethylammonium (TEA) insensitive or sensitive (Thorneloe and Nelson, 2005). TEA is 
a classical Kv channel blocker, from the external or internal side of the pore region 
(Stanfield, 1983; Kirsch et al., 1991; Taglialatela et al., 1991; Yellen et al., 1991; Pascual et 
al., 1995). It is noteworthy herein, that mutations which affect N-type inactivation also 
influence the binding of intracellular channel blocker like TEA (Yellen et al., 1991). In the 
case of external TEA, neuronal Kv1 channels are either sensitive (IC50 = 0.3–10 mM; Kv1.1, 
1.3 and 1.6) or insensitive (IC50 > 100 mM; Kv1.2, 1.4, 1.5 and 1.7) (Gutman et al., 2005). 
 
1.11.2 Kv1 channel inhibition by toxins. In the last few decades, venomous animals 
provided pharmacological tools that can block a variety of Ca2+ activated (e.g. apamin, 
iberiotoxin, charybdotoxin, scyllatoxin), voltage-gated (Kv) (e.g. dendrotoxins (DTX), 
kaliotoxin, conotoxins, hanatoxins, phrixotoxins), and inward-rectifier (tertiapin) K+ 
channels. These toxins have been isolated from scorpion, snake, cone-shell, spider, bee or 
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sea anemone venoms (Mehraban et al., 1984; Breeze and Dolly, 1989; Parcej et al., 1992; 
Smith et al., 1993; Swartz and MacKinnon, 1995; Kauferstein et al., 2003). Due to their 
high specificity and affinity for K+ channels, these toxins have facilitated the purification of 
K+ channels, determination of their subunit stoichiometry and sub-cellular localization and 
tissue distribution (Parcej and Dolly, 1989; Scott et al., 1990; Awan and Dolly, 1991; Reid 
et al., 1992; Aiyar et al., 1995; Wang et al., 1999b; Legros et al., 2000). They have served 
as crucial tools for determining the involvement of particular Kv channels in patho-
physiological pathways. For example, DTXk, mast cell degranulating (MCD) peptide, 
kaliotoxin and ShK peptide, isolated from snake, bee, scorpion and sea anemone venoms, 
respectively, were of primary importance in characterizing the function of Kv1.1 channels 
in epilepsy and the contribution of Kv1.3 channels in inflammatory processes (Bagetta et al., 
1997; Mourre et al., 1997; Wang et al., 1999a; Beeton et al., 2001, 2003).  
 
1.12 Aims of this study 
The group of Prof. Oliver Dolly has been focusing on characterizing the biophysical 
profiles of Kv1 oligomers (Shamotienko et al., 1997; Shamotienko et al., 1999; Wang et al., 
1999) in order to establish their pharmacological criteria (Al-Sabi et al., 2010) with the aim 
of enhancing the effectiveness of selective inhibitors in treating neurological disorders 
(such as MS). This study was intended to assess the functional significance of Kv subunit 
compositions and their stoichiometry in Kv1 channel subtypes. In addition, the biophysical 
and pharmacological profiles of Kv1 channels expressed in mammalian cell were 
determined. Main objectives of this research were: (1) Re-creating ‘native-like’ neuronal 
Kv1 oligomers, using an established tandem-linked strategy (Al-Sabi et al., 2010), and 
evaluating their structural/functional characteristics as well as surface expression as intact 
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multimers in human embryonic kidney (HEK)-293 cells; (2) Exploiting the functioning of 
the NIP domain of Kv1.6 α subunit on rapid inactivation of Kv1.4-containing channels, 
mediated through a NIB to prove the effectiveness of the concatenation; (3) Exploring how 
positioning of Kv1α subunit genes in tandem-linked constructs influence the assembly and 
biophysical/pharmacological properties of hetero-tetrameric K+ channels when expressed in 
HEK-293 cells; (4) Investigating the biophysical changes in K+ currents by incorporating 
one or more mutations into Kv1.2 of Kv1.1/1.2-containing tetramers; and (5) Utilizing the 
proprietary recombinant Kv1 subtypes, representative of those in neurons, for screening Kv1 
channel selective inhibitors to normalize aberrant K+ channel function to ameliorate disease 
symptoms. 
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CHAPTER 2 
 
MATERIALS AND METHODS 
 
2.1 Materials 
Molecular biology: Kv1.X genes in pAKS plasmid were a gift from Prof. Olaf Pongs 
(University of Hamburg, Germany). The vector, pβUT2, was a gift from Dr. Adam 
Rodaway (Kings College, London, UK), pIRES2-EGFP vector were purchased from 
Clontech, Ireland. PCR-blunt plasmid, Platinum® Pfx DNA Polymerase, TOP10 competent 
cells, and SOC medium were from Invitrogen, Ireland. HiSpeed plasmid purification kits 
were from Qiagen, UK. Restriction enzymes and 1 Kb DNA ladder were purchased from 
New England Biolabs, UK. Sigma–Aldrich (Ireland) supplied DNA gel loading solution.  
 
Cell culture reagents: Dulbecco’s Modified Eagle’s Medium (DMEM, D6429), 0.25% 
(w/v) trypsin/EDTA, antibiotic/antimycotic (anti/anti) solution, glutathione and poly-D-
lysine were bought from Sigma-Aldrich, Ireland. GIBCO (Ireland) supplied Accutase, 
Geneticin and B-27 supplement. Polyfect and TransIT®-2020 transfection reagents were 
purchased from Qiagen, UK and Mirus Bio LLC, Ireland, respectively. Bio-Sciences 
supplied Hank’s balanced salt solution (HBSS). EXCELL® animal-component-free 
medium was purchased from SAFC Biosciences, UK. 
 
Protein Biochemistry: EZ-Link Sulfo-NHS-LC-Biotin, Pierce® Streptavidin–agarose beads 
and Pierce® BCA protein assay kit were purchased from Thermo Scientific, Ireland. 
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Calbiochem protease inhibitor cocktail set III was purchased from Merck Millipore. Details 
of all the primary antibodies used are given as follows.  
 
Table 2.1 List of primary antibodies used for Western blotting  
Name of the antibody Dilution used Supplier 
Mouse monoclonal anti-Kv1.1, clone K20/78 1:10 (WB) NeuroMab, USA 
Mouse monoclonal anti-Kv1.2, clone K14/16 1:10 (WB) NeuroMab 
Mouse monoclonal anti-Kv1.4, clone K13/31 1:10 (WB) NeuroMab 
Rabbit polyclonal anti-Kv1.6, ab65792 1:500 (WB) Abcam, UK 
 
Western blotting secondary antibodies: donkey anti-mouse antibody (1:10,000) and anti-
rabbit antibody (1:10,000) were purchased from Jackson ImmunoResearch laboratories 
Inc., UK. Bio-Rad (Ireland) supplied protein molecular weight markers. 4-AP was 
purchased from Lancaster Synthesis, UK and TEA from Sigma-Aldrich, Ireland. All other 
chemicals were from Sigma-Aldrich, Ireland.  
 
2.2 Methods 
 
2.2.1 PCR amplification of Kv1 channel genes with flanking half-linkers and unique 
restriction enzyme sites 
Concatenation of four Kv subunits as a single open reading frame (ORF) was accomplished 
using an inter-subunit linker derived from the untranslated regions (UTRs) of the Xenopus 
β-globin gene (GeneBank® accession number J00978) (Sokolov et al., 2007). When 
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sequenced, the Kv1.1, 1.2, 1.4 and 1.6 constructs corresponded to those previously 
published GI number (see list of abbreviations for full form): 148356232, GI: 148298857, 
GI: 205042, GI: 253970438, GI: 467797 and GI: 499327, respectively. Amplification of Kv 
channel genes was carried out using Kv sequence-specific primers which incorporated 
flanking XbaI/XhoI sites (Table 2.2A), allowing their individual cloning into a previously 
modified UTR-containing intermediate pβUT plasmid, at XbaI/XhoI cloning sites (Al-Sabi 
et al., 2010). A second round of PCR, using primers specific to the UTRs themselves, 
allowed amplification of α subunit ORF contiguous with the flanking UTRs and paired 
restriction sites for NheI/BglII, BglII/EcoRI, EcoRI/SalI and SalI/BamHI (Table 2.2B). To 
insert a gene into position IV of a tetramer, Kv gene subunits were engineered with stop 
codon(s). Thus, UTR-specific primers for positions I, II, III and IV differed only by 
position-specific flanking restriction sites. A bank of monomeric α Kv1.1, 1.2 and 1.6 gene 
subunits were generated and cloned into the multiple cloning site (MCS) of expression 
vector pIRES2-EGFP. To construct Kv1.4-containing tetramers, Kv1.4 gene was amplified 
using specific primers for NheI and BglII sites without inter-subunit linker (Table 2.2C).  
 
Table 2.2 PCR primers used to amplify Kv α subunits and insert restriction sites 
A 
Rat Kv1 
α subunit 
Forward primer 
(with XbaI site underlined) 
Reverse primer 
(with XhoI site underlined) 
1.1 GTCTAGAATGACGGTGATGTCAGGGGAGAATGC GCTCGAGAACATCGGTCAGGAGCTTGCTCTTATTAAC (-); 
GCTCGAGTTATCAAACATCGGTCAGGAGCTTGCTCTTATTAAC (+) 
1.2 GTCTAGAATGACAGTGGCTACCGGAGACCCAGTGG GCTCGAGGACATCAGTTAACATTTTGGTAATATTCAC (-); 
GCTCGAGTTATCAGACATCAGTTAACATTTTGGTAATATTCAC (+) 
1.6 GTCTAGAATGAGATCGGAGAAATCCCTTACGC GCTCGAGAACCTCGGTGAGCATCCTTTTCTCTGC (-); 
GCTCGAGTTA AACCTCGGTGAGCATCCTTTTCTCTGC (+) 
 
39 
 
B 
Subunit 
position in 
pIRES 
Forward primer 
(restriction site underlined) 
Reverse primer 
(restriction site underlined) 
I (NheI-BglII) AGCTAGCAGAATAAACGCTCAACTTTGGCAGATC GAGATCTCCAGATCCGGTACCAGATCGATCTCGAC 
II (BglII-EcoRI) GAGATCTAGAATAAACGCTCAACTTTGGCAGATC CGAATTCCCAGATCCGGTACCAGATCGATCTCGAC 
III (EcoRI-SalI) CGAATTCAGAATAAACGCTCAACTTTGGCAGATC AGTCGACCCAGATCCGGTACCAGATCGATCTCGAC 
IV (SalI-
BamHI) 
AGTCGACAGAATAAACGCTCAACTTTGGCAGATC AGGATCCCCAGATCCGGTACCAGATCGATCTCGAC 
C 
Rat Kv1.4 in 
position I 
Forward primer 
(restriction site underlined) 
Reverse primer 
(restriction site underlined) 
NheI-BglII GAATCAGCTAGCATGGAGGTGGCAATGGTGAG GAATCAAGATCTCACATCAGTCTCCACAGCCTTTG 
 
2.2.2 Site-directed mutagenesis of Kv1 channel constructs 
Selected mutations R354A, V381Y, R354A/V381Y, Q357H/V381Y or 
Q357H/P359S/V381Y in the pore region of Kv1.2 (Table 2.3, and cf. Fig. 3.1 later), were 
sequentially introduced by using inverse PCR with suitable primers, Pfx high-fidelity 
polymerase and Kv1.2 monomer as a template, followed by self-ligation. The NIP function 
of Kv1.6 was abolished by carrying out amino acid substitutions identified by others 
(Roeper et al., 1998). Briefly, Kv1.6 was mutated using Pfx polymerase in the presence of 
primers to substitute NIP residues, glutamic acid 27, 30 and 32, with alanines, thereby, 
yielding the mutant (Kv1.6 E27/30/32A) (Table 2.3). After verification of the resultant 
mutants by DNA sequencing, each gene was subsequently cloned into the desired position 
of selected tetrameric constructs (cf. Fig. 3.6 and 4.7 later). 
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Table 2.3 List of mutations created in Kv genes 
Rat Kv 
gene  
Position of  
mutation in 
protein  
Amino acid conversion Mutated Kv gene 
created  
1.2 354* Arginine (CGA) to Alanine (GCA) 1.2(R354A) 
1.2 381 Valine (GTT) to Tyrosine (TAT) 1.2
(V381Y)
 
1.2 354 and 381 Arginine (CGA) to Alanine (GCA) and 
Valine (GTT) to Tyrosine (TAT) 
1.2
(R354A/V381Y)
 
1.2 357 and 381 Glutamine (CAG) to Histidine (CAC) and  
Valine (GTT) to Tyrosine (TAT) 
1.2
(Q357H/V381Y)
 
1.2 357, 359 and 
381 
Glutamine (CAG) to Histidine (CAC),  
Proline (CCC) to Serine (TCC) and Valine (GTT) 
to Tyrosine (TAT) 
1.2
(Q357H/P359S/V381Y)
 
1.6 27, 30 and 32 Glutamic acid (GAG) to Alanine (GCG) 1.6
(E27/30/32A)
 
* = amino acid residue number 
Conditions for amplification using Pfx high-fidelity polymerase were: initial denaturation, 
95oC for 2 minutes, 22 cycles of amplification, each cycle comprising denaturation at 94oC 
for 30 seconds, annealing Tm of primers for 45 seconds and elongation at 68oC for 2 
minutes. PCR products were purified by gel electrophoresis followed by band recovery, and 
cloned into subsequent vectors. 
 
2.2.3 Assembly of monomeric Kv1 gene cassettes to generate pre-defined tetrameric 
constructs 
A bank of Kv1α gene(s) cassettes generated after insertion of inter-subunit half-linkers (5’ – 
end linker amino acid sequence:   R   I   N   A   Q   L   W   Q   I   D   S   R;  3’ – end linker 
amino acid sequence:  L   E   T   S   R   S   I   W   Y   R   I   W) and position-specific 
restriction enzyme sites (Fig. 2.1), were trimmed with chosen pair(s) of position-dependent 
restriction enzymes (NheI/BglII, BglII/EcoRI, EcoRI/SalI or SalI/BamHI) and sequentially 
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sub-cloned into each of the four position(s) (I–IV) of pIRES2-EGFP to generate multimeric 
construct(s) (Al-Sabi et al., 2010). Each single α subunit encoding gene fragment in 
Kv1.1/1.2-containing tetramers was separated by a combined 78 bp linker including 
restriction enzyme sites. In Kv1.4-containing concatemers, Kv1.4 gene inserted into position 
I was separated from the second subunit by a 42 bp linker including a BglII restriction site. 
In all the constructs, a subunit gene followed by a stop codon was sub-cloned in position 
IV. The DNA constructs generated were transformed in TOP10 chemically competent 
E.coli and selected on the antibiotic resistant Luria-Bertani (LB) agar containing the 
appropriate antibiotic, kanamycin sulphate (30 µg/ml). Selected bacterial clones were 
grown in large volumes (500 ml) and DNA was isolated using HiSpeed plasmid 
purification kits from Qiagen, UK. 
 
Fig. 2.1 Representation of the positional arrangement of genes sub-cloned into an expression vector 
(pIRES) to generate multimeric constructs.  
Four α subunit genes were trimmed on both ends with restriction enzymes and such cassette(s) were 
sub-cloned into an expression plasmid containing a reporter gene, to generate multimeric 
construct(s) into desired positions. The postions I- IV in a multimeric construct were linked by a 78 
bp linker (complete recombinant linker), including restriction enzyme sites (BglII, EcoRI or SalI) in 
Kv1.1/1.2-containing tetramers, whereas a 42 bp linker, including the enzyme site (BglII), joined 
position I and II subunits in Kv1.4 -containing tetramers. The gene(s) inserted in I, II and III were 
devoid of a stop codon, whereas the gene in the fourth position is carrying stop codon(s) at the 
3’end.   
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2.2.4 DNA mapping 
All recombinant DNA constructs were analysed by digestion with various restriction 
enzymes and sequenced to confirm their identities. 
2.2.4.1 Restriction enzyme digestion analysis of recombinant DNA constructs. Purified 
maxi DNA preparations of desired recombinant Kv gene constructs (monomers and 
tetramers) were analysed by restriction enzyme digestion, throughout the cloning process, 
for their correct orientation and positioning in cloning and expression vectors. Monomeric 
Kv1.1, 1.2 and 1.6 in pIRES2-EGFP vector with stop codon(s) were digested with 
SalI/BamHI. Tetrameric constructs are digested with NheI/BglII, BglII/EcoRI, EcoRI/SalI 
and SalI/BamHI to release the genes sub-cloned in position I-IV, respectively. Enzymes 
that were used to identify the genes incorporated in the vectors are listed in the Table 2.4.  
Table 2.4 List of restriction enzymes used to confirm the chosen cloning site in a 
vector and the identity of respective Kv genes cloned 
Construct Vector Gene(s) Restriction enzymes used to confirm 
Position in the  
MCS of vector 
Gene 
incorporated 
Tetrameric α 
Kv1.1-pIRES 
pIRES2-EGFP Kv1.1 NheI/BglII,  
BglII/EcoRI, EcoRI/SalI  
& SalI/BamHI 
SphI 
Tetrameric α 
Kv1.2-pIRES 
pIRES2-EGFP Kv1.2 NheI/BglII,  
BglII/EcoRI, EcoRI/SalI  
& SalI/BamHI 
EcoRV 
Tetrameric α 
Kv1.1/1.2-pIRES 
pIRES2-EGFP Kv1.1 and 
1.2 
NheI/BglII,  
BglII/EcoRI, EcoRI/SalI  
& SalI/BamHI 
EcoRV, SphI 
Tetrameric α 
Kv1.4/1.6/1.2-
pIRES 
pIRES2-EGFP Kv1.4, 1.6 
and 1.2 
NheI/BglII,  
BglII/EcoRI, EcoRI/SalI 
& SalI/BamHI 
EcoRV, SphI 
and KpnI  
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All the enzyme digestions were kept at 37 oC for 2 h, mixed with DNA gel loading solution 
followed by electrophoresis through 0.85 % agarose gel. 1 Kb DNA ladder was used as a 
reference marker.  
 
2.2.4.2 Confirmation of recombinant Kv channel genes by DNA sequencing. In addition to 
the restriction analysis, all the wild-type and mutated forms of the monomeric and 
tetrameric constructs built herein were subjected to DNA sequencing (Eurofins MWG, 
Germany), to verify correct nucleotide sequence of the genes. For sequencing monomeric 
Kv1 channel genes in a vector, primers were designed corresponding to the nucleotide 
sequence of the respective genes and to the sequence of vector near to the 5’ end and 3’ end 
of the incorporated gene. DNA samples were prepared without restriction digestion. 
However, to sequence concatenated multimeric constructs, each subunit was isolated from 
a tetramer by digestion with position-specific restriction enzymes (NheI/BglII, BglII/EcoRI, 
EcoRI/SalI and SalI/BamHI), if more than one copy of the same Kv gene was present. To 
sequence the linker region in a tetramer, a set of two genes was isolated by restriction 
digestion while preserving the linker region, gel extracted, followed by DNA sequencing 
using primers designed to complement sites near to the linker sequence (Fig. 2.2). Primers 
complementary to the pIRES vector sequence near to the 5’ (pIRES forward) or 3’ (pIRES 
reverse) end of complete tetrameric construct were used to sequence position I or position 
IV subunit when left intact with vector after isolation of remaining subunits. When isolated, 
each subunit was sequenced with the gene-specific primers (Fig. 2.2). 
 
44 
 
 
Fig. 2.2 Strategy applied to sequence a tetrameric construct.  
The pattern of primers designed to sequence each individual subunit encoding fragment of gene(s) 
of a complete tetramer is depicted. The pIRES forward and reverse primers were used to sequence 
subunits in position I and IV, respectively, along with gene-specific primers (arrows with asterisk). 
Total sequencing of tetrameric DNA was performed by releasing desired subunits with restriction 
digestion, gel (0.85% agarose) electrophoresis and extraction followed by nucleotide sequencing. 
 
2.3 Cell culture 
2.3.1 Culturing of mammalian cells 
Mammalian cell lines, Human Embryonic Kidney (HEK)-293 (ATCC, UK), were 
maintained in DMEM supplemented with 10 % fetal (v/v) bovine serum (FBS), 100 IU/ml 
of Penicillin and 100 µg/ml of Streptomycin, as adherent cultures in a 5% CO2 incubator at 
37 °C. Cells were trypsinised (0.25% (v/v) Trypsin-EDTA solution, Cat no. T4049 Sigma-
Aldrich Ireland) and re-plated once they reached 80 % confluency. For long-term storage in 
liquid nitrogen, cells were kept in FBS containing 10 % (v/v) dimethyl sulfoxide (DMSO). 
Cells were then processed as required. 
 
For electrophysiology experiments, coverslips were washed thoroughly with concentrated 
nitric acid, followed by rinsing with deionised water, sterilized by autoclaving and dried in 
culture dishes before using. One coverslip (9 mm diameter) per well was placed in a 24 
well plate or an appropriate culture dish. For coating, poly-D-lysine solution (500 µl of 0.1 
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mg/ml, dissolved in sterilized double distilled water) was added to the wells/culture dishes 
with or without coverslips. After 30 min of incubation at room temperature, wells/culture 
dishes were washed twice with sterile water and dried. Coated dishes were stored at room 
temperature until use. 
 
2.3.2 Transfection of HEK-293 cells using Polyfect or TransIT-2020 
Approximately 18–24 h before transfection, HEK-293 cells at a density of 3.0 × 105 
cells/ml were plated in 2.5 ml complete growth medium per well in a 6-well plate. After 
overnight incubation, cells ≥ 60% confluence were transfected. Plasmid DNA (2.5 µg) was 
added to 250 µl of DMEM without antibiotics and serum. Polyfect or Mirus TransIT®-
2020 reagent was added to the diluted DNA according to the manufacturer’s 
recommendations. After gentle pipetting, the mixture was incubated at room temperature 
for 15 minutes to allow DNA/reagent complex to form. Serum supplemented DMEM was 
added to the DNA/reagent mixture and the total volume transferred to the cells with gentle 
swirling to ensure even distribution of the complexes. Cells were then incubated at 37 °C, 
in a 5 % CO2 atmosphere for 48 h to allow gene expression. 
 
2.3.3 Generation of monoclonal and polyclonal stable cell lines expressing Kv1 channels 
Post transfection HEK-293 cells were allowed to grow for 48 hrs in culture medium.  
Adherent cells were trypsinised, washed with PBS and allowed to grow for ~2-3 weeks in 
culture medium at a final concentration of 500 µg/ml of geneticin (Life Technologies).  
Culture supernatant was replaced with fresh medium (containing geneticin) as the non-
transfected cells started to die and float during incubation. Surviving cells (referred as 
polyclonal) expressing enhanced green fluorescent protein (EGFP) marker were detached 
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and plated at a density of 1 cell/well in a 24-well plate.  Clones stably expressing Kv1.X 
gene with EGFP (referred as monoclonal) were selected and analysed by microscopy, 
before further analysis by surface biotinylation and electrophysiology.  
 
2.4 Characterization of recombinant gene expression in HEK-293 cells  
2.4.1 Biotinylation and isolation of cell surface expressed proteins in HEK-293 cells  
Biotinylation of cells was performed as depicted in Fig. 2.3. Briefly, cells were washed 
twice with ice-cold PBS. EZ-Link Sulfo-NHS-LC-Biotin at 1 mg/ml in ice-cold PBS was 
added to each flask and placed for 30 minutes at 4°C with gentle agitation for every 5 min. 
The reaction was quenched by adding glycine to a final concentration of 100 mM in PBS to 
each flask. Cells were scraped off the surface and centrifuged at 500 × g for 3 min after 
rinsing the flask with 1xTris-buffered saline (TBS). Supernatant was discarded and cells 
were washed twice with PBS at 500 × g for 3 minutes. Cell lysis was performed by 
suspending the cells in 500 µl of 1 x lysis buffer containing protease inhibitors cocktail 
(1:200 dilution, Cat. no. P8340 Sigma-Aldrich Ireland) and incubated for 60 minutes on an 
end-over-end rotator at 4°C. Lysate was centrifuged at 10,000 × g for 10 minutes at 4°C 
and clarified supernatant was collected. Meanwhile, Streptavidin agarose beads (total 
volume of 150 µl of slurry) were sedimented for 1 min at 1,000 × g. After the supernatant 
was discarded, the resin was washed twice with 500 µl of cell lysis buffer, centrifuged for 1 
minute at 1,000 × g and the supernatant discarded. The clarified cell lysate was applied to 
the washed resin and incubated for 60 minutes at 4°C on a rotator. Then, the resin with cell 
lysate was centrifuged for 1 minute at 1,000 × g and the flow-through retained. The resin 
was washed three times; 1 minute at 1,000 × g, with 500 µl wash buffer supplemented with 
protease inhibitors cocktail. 1 x Lithium dodecyl sulfate (LDS) sample buffer (100 µl) 
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containing a final concentration of 50 mM DTT was added to the resin and heated for 5 
minutes at 95°C. The samples were centrifuged for 5 min at 10,000 × g, the supernatant 
collected and stored at -20°C for further analysis. 
 
 
Fig. 2.3 Schematic of experimental steps to characterize cell-surface expressed Kv proteins using EZ-
Link Sulfo-NHS-LC-Biotin.  
Cells were labelled with EZ-Link Sulfo-NHS-LC-Biotin, subsequently lysed with a mild detergent 
and the labelled proteins then isolated with agarose beads. The bound proteins released by 
incubating with SDS-PAGE sample buffer were analysed by Western blotting. 
 
2.5 Electrophysiological recordings 
Whole-cell voltage clamp was performed as outlined previously (Al-Sabi et al., 2010), 
except where specified. In the conventional patch-clamp system (EPC10 amplifier; HEKA 
Elektronik, Germany), the recording pipette was filled with an internal solution of the 
following composition: 95 mM KF, 30 mM KCl, 1 mM CaCl2, 1mM MgCl2, 11 mM 
EGTA, 10 mM Hepes and 2 mM Na2ATP (pH 7.2 with KOH), with fire-polished tips 
having resistances between 1.5 and 3.0 MΩ. To ensure functionality of the NIB moiety, 2 
mM glutathione was introduced as a reducing agent to the internal solution (Ruppersberg et 
al., 1991; Roeper et al., 1998). The external (bath) medium contained: 135 mM NaCl, 5 
mM KCl, 2 mM CaCl2, 2 mM MgCl2, 5 mM Hepes and 10 mM sucrose (pH 7.4 with 
NaOH). Correction was made for liquid junction potential (+7 mV). Only cells with an IK 
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of >1 nA were chosen for experimentation to avoid interference from endogenous outward 
currents (< 200 pA at +20 mV potential). Likewise, only cells with series resistances <10 
MΩ throughout the experiments were included in the present study. Leakage and capacitive 
currents were subtracted online using the P/4 subtraction protocol. Currents were filtered at 
1 kHz, and sampled at 10 kHz (with the exception of 10 seconds pulses, which were 
sampled at 50 Hz). Whole-cell currents were measured at a holding potential of −90 mV, 
and then depolarized to +20 mV for 300 ms or stepped from the holding potential in +10 
mV increments from −80 mV to 80 mV. gK–V (K+ conductance–voltage relationships) 
were determined from averaged steady-state currents after 200 ms of activation and 
normalized relative to the K+ driving force, by assuming a reversal potential of −82 mV. 
Time constants for activation were determined by fitting the IK amplitudes corresponding to 
40–90 % of the maximum with a single exponential function. Time-dependent inactivation 
constants were measured during 10 seconds depolarization steps from −10 to 10 mV, in 10 
mV increments, and the currents fitted with double exponential functions (Sokolov et al., 
2007). For experiments on the recovery from inactivation, a variable interval-gapped pulse 
protocol was used; from a −90 mV holding potential, depolarization to +10 mV for 300 ms 
in an initial step was followed by a second identical pulse with gap intervals of 0–20 
seconds. The ratios of the normalized peak currents at time intervals were plotted and fitted 
with a single exponential function to obtain time courses of recovery from inactivation. 
Measurement of steady-state inactivation involved a 10 seconds conditioning pulse applied 
in 10 mV increments from −100 to +10 mV, followed by a 500 ms test pulse at +10 mV (at 
−90 mV holding potential). Steady-state inactivation constants were calculated from the 
peak currents of the test pulses. Normalized inactivation curves were fitted to the 
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Boltzmann function (I = {1+exp[(V −V1/2)/k]}−1), where V is the membrane (pre-pulse) 
potential, V1/2 is the potential at half-maximal inactivation and k is the slope factor.  
An automated whole-cell voltage clamp system (QPatch 16, Sophion Bioscience) was 
utilized as outlined previously (Al-Sabi etal., 2010), using the same internal and external 
solutions as in the conventional system, and with Qplate pin-holes having resistances 2–3 
MΩ. TEA chloride was substituted for an equivalent amount of NaCl. HEK-293 cells 
expressing the desired Kv1 channel were detached from culture plates with Accutase and 
suspended in EXCELL® animal-component-free medium, 25 mM Hepes and 5 mM L-
glutamine (pH 7.4)] and washed twice with external solution before being applied to the 
pipetting wells in the Qplate. Giga-seals were formed following execution of a combined 
suction/voltage protocol; gradually increasing suction leads to the whole-cell configuration. 
Compounds were applied, via a four-way pipetting robot, through integrated glass-coated 
microfluidic flow channels. Data analysis was performed using an integrated database 
(Oracle) within QPatch software (Sophion Bioscience). TEA inhibition was determined by 
the Hill equation fitted to six to eight concentrations. A Dynaflow-16 perfusion system 
(Cellectricon) in the conventional patch-clamp rig, where test solutions were exchanged by 
continuous microfluidic flow, was used to confirm the results made by the QPatch 16. In 
the Dynaflow-16 system, data were taken from one to six TEA concentrations to quantify 
the inhibition, according to the relationship IC50 = fc/(1−fc)[TEA], where fc is the 
fractional current and [TEA] is the TEA concentration.  
 
2.6 Data analysis 
Electrophysiological results were analysed using FitMaster (HEKA Electronik), re-plotted 
and fitted using IGOR Pro 6 (WaveMetrics, USA). Data are reported as means + S.E.M. 
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and n values refer to the number of individual cells tested. Statistical significance was 
evaluated by an unpaired two-tailed Student’s t test or, where indicated in the text, a Mann–
Whitney U test, using data obtained from at least four independent experiments.  
P < 0.01 was considered significant.  
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CHAPTER 3 
 
RESULTS 
 
Position-dependent attenuation by Kv1.6 of N-type inactivation of Kv1.4-
containing channels  
 
3.1 Overview 
Biochemical studies on brain membranes have revealed that Kv1.4 α subunit is a constituent 
of K+ channel oligomers containing Kv1.2 and 1.6 subunits (Shamotienko et al., 1997, 
Coleman et al., 1999). The fast N-type inactivation endowed by Kv1.4 can be prevented by 
the presence of Kv1.6 through its NIP domain (Roeper et al., 1998), giving rise to a much 
slower inactivating/sustained K+ current. As tetramerization of Kv channel subunits occurs 
in the endoplasmic reticulum (Pfaffinger and DeRubeis, 1995), pinpointing their ordering 
in vivo has thus far eluded researchers because of an inability to pre-determine the 
arrangement of their assembled constituents in the oligomers delivered to the cell surface. 
Therefore, it was warranted to focus efforts on gaining a clearer understanding of the 
influences on channel properties of subunit ordering, particularly as the resultant data could 
give insights into the modulation of neurotransmission by Kv1 channels. Furthermore, such 
information is medically relevant given that delayed rectifier Kv1 subunits, but not Kv1.4, 
are down-regulated in the hippocampus of animal models prone to seizures (Lee et al., 
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2009), whereas Kv1.4 is up-regulated following chronic injury of the spinal cord (Edwards 
et al., 2002). 
 
The present study addressed whether subunit ordering influences the biophysical profiles of 
Kv1 channels. For this, advantage was taken of the NIP in Kv1.6 (Roeper et al., 1998) being 
able to prevent fast inactivation of Kv1.4-containing channels. If NIP competes directly for 
the binding site of NIB on Kv1.4, displacing it and giving rise to slow inactivation, no 
differences ought to be expected when these two α subunits are placed adjacently or distally 
in concatenated heteromers, with both of their currents inactivating slowly. On the other 
hand, if NIP function relies on it directly interacting with the NIB, dissimilarities in 
inactivation rates may occur with a slow-inactivating current only occurring when both 
domains are optimally placed. Suboptimal placement might result in a fast-inactivating 
channel when NIP is positioned away from NIB and unable to modulate it. To address this 
important question, inactivation, voltage-dependence of inactivation and recovery from 
inactivation were measured in three recombinantly-expressed tetramers having identical 
subunit composition, but distinct subunit positioning. A fourth tetramer, Kv1.4-1.2-1.2-1.2 
was constructed as a control, having one copy of Kv1.4 within the tetramer. The novel 
outcome of this approach questions the wisdom of predicting channel properties based on 
subunit content alone because their positioning greatly influences the channels’ 
characteristics. Also, the data reaffirm convincingly that this concatenation of genes pre-
determines the positions of α subunits in the assembled functional channels on the cell 
surface. 
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3.2 Channel concatemers of defined α subunit composition expressed following 
domain-specific assembly of gene cassettes into the pIRES2-EGFP plasmid 
In this study, two subunits having opposite roles on inactivation kinetics were selected to 
obtain proof of principle for retaining their functionalities depending on their positioning 
within the concatemer (Fig. 3.1). Kv1.4, which mediates N-type inactivation of mammalian 
Kv1 channels through its NIB domain (Ruppersberg et al., 1991; Tseng-Crank et al., 1993) 
together with Kv1.6, which overrides this rapid inactivation via its NIP domain (Roeper et 
al., 1998), were expressed in different positions with respect to each other. Two or three 
copies of Kv1.2 formed the other constituent of these hetero-tetramers. In one concatenated 
gene construct, Kv1.4 was separated from Kv1.6 with a single copy of Kv1.2 (Kv1.4–1.2–
1.6–1.2), in another case Kv1.6 was placed immediately adjacent to Kv1.4 followed by two 
copies of Kv1.2 (Kv1.4–1.6–1.2–1.2), and the third tetramer had two copies of Kv1.2 
between Kv1.4 and Kv1.6 (Kv1.4–1.2–1.2–1.6), giving three tetramers with identical 
composition of subunit, but different ordering. A fourth construct was assembled 
containing one copy of Kv1.4 along with three copies of Kv1.2 (Kv1.4–1.2–1.2–1.2); this 
was expected to show a rapid inactivating K+ current due to lack of the Kv1.6-containing 
NIP domain (Fig. 3.1).  
 
All tetramer construction employed an inter-subunit linker derived from the Xenopus β-
globin gene shown previously to be suitable (Al-Sabi et al., 2010). Initial PCR of cDNA 
encoding Kv1.4, 1.6 or 1.2, yielded single bands on electrophoresis with the expected sizes 
of ∼2.0, 1.6 and 1.5 Kb, respectively. Flanking inter-subunit linkers and paired restriction 
sites, allowing cloning into the pIRES2-EGFP expression vector, were added to the 
amplified products of Kv1.2 and/or Kv1.6 as described (Al-Sabi et al., 2010).  
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Fig. 3.1 Schematics showing predicted arrangement of concatenated channels based on order of Kv1 
genes in recombinant constructs.  
NIB and NIP refer to the Kv1.4 N-terminal inactivation ball and its prevention domain in Kv1.6, 
respectively.  
 
The resultant hetero-tetramers, Kv1.4–1.6–1.2–1.2, Kv1.4–1.2–1.6–1.2, Kv1.4–1.2–1.2–1.6 
and Kv1.4–1.2–1.2–1.2 were assembled into pIRES2-EGFP with the Kv1.4 gene introduced 
at the start (position I) to conserve functionality of its NIB. Kv1.6, when present, was 
placed either adjacently (position II or position IV) or distally (position III) to the Kv1.4 
sequence (Fig. 3.2). Each Kv1 gene incorporated in a tetramer was analysed for their 
positioning (I-IV) by restriction digestion with position-specific enzymes NheI/BglII, 
BglII/EcoRI, EcoRI/SalI and SalI/BamHI, respectively. EcoRV, SphI and KpnI are gene 
specific enzymes used to verify the presence of Kv1.2, 1.4 or 1.6 (Fig. 3.2). Complete DNA 
sequencing analysis of the tetramers in Fig. 3.2 confirmed the presence of desired subunits 
with correct nucleotide sequence. 
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Fig. 3.2 Restriction maps of Kv1.X tetramers.  
Agarose (0.85%) gel electrophoretograms showing the sequential release of each subunit (Kv1.4, 
Kv1.6 or Kv1.2) from tetrameric constructs Kv1.4–1.6–1.2–1.2 (A), Kv1.4–1.2–1.6–1.2 (B), Kv1.4–
1.2–1.2–1.6 (C) and Kv1.4–1.2–1.2–1.2 (D) by digestion with NheI/BglII, BglII/EcoRI, EcoRI/SalI 
and SalI/BamHI respectively. EcoRV, SphI and KpnI are gene-specific restriction enzymes used to 
verify the presence of Kv1.2, 1.4 or 1.6 subunits in desired positions. M, 1 Kb DNA ladder. 
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3.3 Concatenated Kv1.4-containing channel expressed on the surface of HEK-293 cells 
as a single intact protein 
All of the concatenated constructs, upon transfection into HEK-293 cells and following 
surface biotinylation analysis, yielded an expressed protein band on SDS/PAGE at Mr 
∼280 K, when probed with antibodies specific to Kv1.4, 1.6 or 1.2 (Figure 3.3). This band 
represents full-length intact tetrameric protein with a smeared appearance possibly due to 
the highly glycosylated nature of Kv1.4 (Watanabe et al., 2015). A number of faint non-
specific bands were observed with the Kv1.4 antibody at Mr ∼140, 50 and 40 K, whereas a 
lower molecular weight non-specific band was also visible with the Kv1.2 antibody (clone 
14/16, NeuroMab), but have no effect on the Kv1 channel activity when tested 
electrophysiologically. 
 
Fig. 3.3 Surface expression of complete hetero-tetrameric Kv1.4-containing channels on plasmalemma 
of HEK-293 cells.  
Transiently transfected HEK-293 cells expressing Kv1.4–1.2–1.2–1.2 (lanes 1, 5 and 9), Kv1.4–
1.6–1.2–1.2 (lanes 2, 6 and 10), Kv1.4–1.2–1.6–1.2 (lanes 3, 7 and 11) or Kv1.4–1.2–1.2–1.6 (lanes 
4, 8 and 12). Intact cells were biotinylated, detergent solubilized, precipitated with streptavidin–
agarose beads and analysed by Western blotting, using antibodies specific for Kv1.4 (lanes 1–4), 
Kv1.6 (lanes 5–8) or Kv1.2 (lanes 9–12); M, denotes a molecular weight marker (K). 
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3.4 Kv1.6 subunit prevents fast inactivation of K+ currents only when positioned 
adjacent to Kv1.4 in heteromeric channel proteins 
When subjected to a 10-s depolarization step to +10 mV or −10 mV, the expressed Kv1.4–
1.2–1.6–1.2 channel displayed a rapidly inactivating A-type K+ current (Fig. 3.4A), which 
is notable as this heteromer contains a NIP domain known to disallow N-type fast 
inactivation (Roeper et al., 1998). Such rapid decay suggests that distal positioning of the 
NIP-containing Kv1.6 relative to Kv1.4 in this heteromer attenuates NIP functionality. This 
fast inactivation profile of Kv1.4–1.2–1.6–1.2 channel is similar to that of Kv1.4–1.2–1.2–
1.2 (Fig. 3.4B). In stark contrast, heteromers Kv1.4–1.6–1.2–1.2 and Kv1.4–1.2–1.2–1.6 
yielded slow-inactivating currents (Fig. 3.4C, D) as expected, due to the dominant-negative 
effect of the NIP domain in Kv1.6 (Roeper et al., 1998).  
 
 
Fig. 3.4 Representative current traces, in response to a two-pulse steady-state inactivation protocol, for 
each depicted channel showing fast inactivation only when Kv1.6 subunit is absent or in a distal position 
from Kv1.4.  
Currents obtained with Kv1.4–1.6–1.2–1.2 and Kv1.4–1.2–1.2–1.6 channels are slow-inactivating; 
while Kv1.4–1.2–1.6–1.2 and Kv1.4–1.2–1.2–1.2 showed fast decay. (n = 4-7). 
 
Current traces from the three heteromeric (Kv1.4/1.6/1.2-containing) channels were best 
fitted with a double exponential function, which revealed significant differences in 
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inactivation rates (Fig. 3.5A). Accordingly, the K+ current resulting from heteromers where 
Kv1.4 and 1.6 were placed adjacently (Kv1.4–1.6–1.2–1.2 and Kv1.4–1.2–1.2–1.6) showed 
slower τ1inact and τ2inact values than those of Kv1.4–1.2–1.6–1.2 and Kv1.4–1.2–1.2–1.2, 
especially at more negative potentials (Fig. 3.5A, Table 3.1). The fast-inactivating channels 
(Kv1.4–1.2–1.6–1.2 and Kv1.4–1.2–1.2–1.2) gave fairly constant τ1inact and τ2inact values at 
different potentials, while the slow-inactivating channel counter-parts revealed variable 
τ1inact, but not τ2inact, values, corresponding to optimal or suboptimal positioning of Kv1.4 to 
1.6 subunits. Among the two slow-inactivating channels, differences in τ1inact values at 
more positive potentials can be correlated with shifting the Kv1.6 subunit from the second 
to the fourth position, which might affect the NIP functionality. A steady-state inactivation 
protocol demonstrated the influence of NIP positioning in the concatemers on the voltage 
dependence of inactivation. The ensuing results, fitted by a single Boltzmann function (Fig. 
3.5B, Table 3.1), unveiled a difference in the midpoints for voltage-dependent inactivation. 
Hetero-tetramers where Kv1.6 and 1.4 subunits are in adjacent positions showed V1/2 values 
of −32 mV for Kv1.4–1.6–1.2–1.2, and −31 mV for Kv1.4–1.2–1.2–1.6 with a significant 
shift (P < 0.05) compared with −40 mV for Kv1.4–1.2–1.6–1.2 and −49 mV for Kv1.4–1.2–
1.2–1.2. Also, membrane potentials more negative than −70 mV were required to remove 
inactivation from all heteromers tested (Fig. 3.5B). 
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Fig. 3.5 Inactivation kinetics of K+ currents are strongly dependent on the position of Kv1.6 relative to 
Kv1.4 in the concatemers.  
(A) The histograms display the mean time constant of inactivation (τ1 and τ2) for the representative 
channels at different potentials. *, P < 0.05, Mann-Whitney U test. (B) The steady-state inactivation 
relationship, taken from normalized peak currents triggered by pre-pulse potentials and fitted with a 
single Boltzmann function. This plot shows a significant (P < 0.05, Mann-Whitney U test) voltage 
shift for Kv1.4-1.6-1.2-1.2 (○, broken line) and Kv1.4-1.2-1.2-1.6 (▲, broken line) to more positive 
potentials compared to Kv1.4-1.2-1.6-1.2 channels (●, straight line) or Kv1.4-1.2-1.2-1.2 (∆, 
straight line) channels, as a result of Kv1.6 NIP functionality. Error bars represent means ± S.E.M. 
in panel A and B. (n = 4-7). 
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Table 3.1 Summary of inactivation parameters for Kv1.4-containing heteromers 
expressed in HEK-293 cells 
 
Results recorded are presented as means + S.E.M., n-values (same for τ1inact and τ2inact) are in 
brackets *, values are significant when compared to Kv1.4–1.2–1.6–1.2, P < 0.05 (Mann-Whitney U 
test). 
 
The recovery from inactivation was studied with a step from −90 to 10 mV, using a 
variable interval-gapped pulse protocol (Fig. 3.6A). Analysis of the time dependence of 
recovery from inactivation (Fig. 3.6B, Table 3.1) revealed that this is significantly faster for 
Kv1.4–1.6–1.2–1.2 followed by Kv1.4–1.2–1.2–1.6, than that observed for Kv1.4–1.2–1.6–
1.2 (Fig. 3.6B, Table 3.1), as a result of the removal of Kv1.4 N-type inactivation by the 
adjacently-placed Kv1.6 NIP. Likewise, the time dependence of recovery from inactivation 
for Kv1.4–1.6–1.2–1.2 was faster than that recorded for Kv1.4–1.2–1.2–1.2. On the other 
hand, the presence of a residual fast component in the K+ current of Kv1.4–1.2–1.2–1.6 
might be affecting the τ value for recovery due to the suboptimal adjacent positioning of 
Kv1.4 subunit to Kv1.6.  
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Fig. 3.6 Recovery from inactivation is faster when Kv1.6 is adjacent to Kv1.4 in the concatemers.  
(A) Recovery from inactivation measured for Kv1.4-1.2-1.2-1.2, Kv1.4-1.2-1.6-1.2, Kv1.4-1.6-1.2-
1.2 and Kv1.4-1.2-1.2-1.6, using variable interval-gapped pulse protocol (inset). (B) The resultant 
curves, fitted with a single exponential function show a significantly faster (P < 0.05, Mann-
Whitney U test) recovery from inactivation for Kv1.4-1.6-1.2-1.2 (○, broken line) and Kv1.4-1.2-
1.2-1.6 (■, broken line) than observed for the Kv1.4-1.2-1.6-1.2 channel (●,unbroken line). This is 
due to the removal of Kv1.4 N-type inactivation by the Kv1.6 NIP domain. Notice the slow recovery 
from inactivation for Kv1.4-1.2-1.2-1.2 (∆, unbroken line) channel compared to Kv1.4-1.6-1.2-1.2. 
Some error bars fall within the data symbols; dotted lines indicate zero current. Data are 
summarized in Table 3.1. (n = 4-7). 
 
3.5 Mutagenesis proved that attenuation of N-type inactivation by Kv1.6 is mediated 
by NIP 
Having demonstrated modulation of the Kv1.4 NIB by Kv1.6 within concatenated hetero-
tetramers of pre-determined ordering, it was necessary to ascertain if these observed effects 
are entirely attributable to the NIP domain. Mutagenesis of residues in the Kv1.6 α subunit 
identified previously as crucial for NIP function (Roeper et al., 1998), and replacing the 
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wild-type with mutated subunit (E27/30/32A), yielded Kv1.4–1.2–1.6(E27/30/32A)–1.2 and 
Kv1.4–1.6(E27/30/32A)–1.2–1.2 channels (Fig. 3.7). 
 
 
 
Fig. 3.7 Gene mapping of mutations created in Kv1.6 subunit of Kv1.4-containing hetero-tetramers.  
(A) Position-specific restriction enzyme (NheI/BglII, BglII/EcoRI, EcoRI/SalI and SalI/BamHI) 
digestion of Kv1.4–1.6mut–1.2–1.2 (A1) and Kv1.4–1.2–1.6mut–1.2 (A2) released each subunit 
(Kv1.4, 1.6 or 1.2) in tetrameric constructs. EcoRV, SphI and KpnI are gene-specific restriction 
enzymes used to verify the presence of Kv1.4, 1.6 or 1.2 subunits in desired positions. A SacII site 
was deliberately introduced into mutant Kv1.6 gene which is absent from Kv1.4, 1.2 subunits and 
the pIRES2-EGFP vector (after digestion with NheI/BamHI). As expected, SacII linearized the 
tetramers containing the Kv1.6 mutant (A1 and A2). M, 1 Kb DNA ladder. (B) Analysis of Kv1.6 
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NIP mutant nucleotide sequence by DNA sequencing confirmed conversion of the codons for three 
glutamic acids at 27, 30 and 32, to alanine within the NIP domain. Sequences: Top line is amino 
acid sequence (numbering was given according to the published mRNA sequence). Middle (sense 
strand) and bottom (anti-sense strand) lines are of nucleotide sequences (numbering was generated 
by the sequencer during sequencing). A distinct colour was assigned to each nucleotide to identify 
their representative traces during sequencing. 
 
 
Fig. 3.8 Position-dependent functioning (Kv1.4 NIB attenuation) of Kv1.6 is NIP-mediated: replacement 
of Kv1.6 with a mutant form abolished NIP activity, thereby restoring rapid inactivation.  
(A) Representative current traces for channels with mutated Kv1.6 (E27/30/32A) incorporated 
(Kv1.4-1.6-1.2-1.2 and Kv1.4-1.2-1.6-1.2) and expressed in HEK-293 cells. (B) Steady-state 
inactivation relationships obtained for these channels, fitted by a Boltzmann function [broken line 
for Kv1.4-1.6-1.2-1.2 (□) and unbroken line for Kv1.4-1.2-1.6-1.2 (■)], revealed near-identical 
profiles. (C) The bar diagrams summarize the τ1 and τ2 rates of inactivation of both channels 
observed at different potentials. Error bars represent means ± S.E.M. (n = 4-5). 
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Both tetrameric channels containing Kv1.6 NIP mutant decayed rapidly (Fig. 3.8A). These 
inactivation time courses are similar to those observed with heteromers containing distally 
arranged wild-type Kv1.6 (Fig. 3.8A, Table 3.1), confirming a complete loss of NIP 
function from Kv1.6 can be achieved either by mutation or distal positioning of the wild-
type, each permitting fast inactivation of the K+ current. Both mutated channels showed 
similar values of inactivation for τ1inact and τ2inact at the different potentials tested (Fig. 3.8C, 
Table 3.1) and similar to those observed for the fast inactivating channel, Kv1.4-1.2-1.6-1.2. 
This is attributable to the fast inactivation mediated by Kv1.4 subunit in each heteromer 
where NIP function is attenuated and has no discernible effect on the NIB moiety.  
 
 
Fig. 3.9 Mutating residues critical for NIP interacting with NIB domain creates fast-inactivating 
channels, regardless of Kv1.4 and 1.6 subunit positioning in the concatemer.  
(A) Typical currents showing recovery from inactivation of each hetero-tetramer fitted to a single 
exponential function. (B) When plotted, the average data for each channel, from at least four cells 
gave superimposable curves; some error bars fall within the data points. Error bars represent means 
± S.E.M. (n = 4-5). 
 
These results were supported by the observed restoration of voltage dependence for 
inactivation (V1/2 −37 mV for both channels) and recovery from inactivation for either 
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channel containing the mutated Kv1.6 subunit (Fig. 3.8B, Fig. 3.9A and Fig. 3.9B) to values 
similar to that of Kv1.4–1.2–1.6–1.2 or Kv1.4–1.2–1.2–1.2 (Fig. 3.9B).These corroborative 
data highlight that only the NIP domain in Kv1.6 prevents fast inactivation, whose function 
is dependent on its position relative to the Kv1.4 subunit. 
 
3.6 Discussion 
 
3.6.1 Arrangements of Kv1α genes in constructs determine subunit positions in the 
expressed channels 
The concatenation cloning platform was employed herein for expressing four α subunits as 
a single protein, with pre-determined subunit ordering relative to each other in the 
functional channels which were examined on the plasmalemma. Importantly, and in 
contrast with previous systems (Gagnon and Bezanilla, 2009), the use of inter-subunit 
linkers appears to have ensured retention of the behaviour of pre-positioned subunits as 
illustrated by NIP function observed for Kv1.6. Three such pre-assembled hetero-oligomers 
are presented, all with identical α subunit composition, but in different arrangements, 
containing a single Kv1.4 and 1.6 subunit plus two copies of Kv1.2. This offered the 
advantage over previous studies (Roeper et al., 1998) in allowing the effects of their 
positioning to be examined. Hetero-tetramers (Kv1.4–1.2–1.6–1.2, Kv1.4–1.6–1.2–1.2 and 
Kv1.4–1.2–1.2–1.6) elicited K+ currents, with the first displaying significantly different 
inactivation properties to the other two. Such dissimilarity, together with the uniform nature 
of the currents produced by each concatenated tetramer, established that the gene 
arrangements in the constructs dictate subunit ordering. A fourth heteromer (Kv1.4–1.2–
1.2–1.2) possessing a single Kv1.4 subunit with three copies of Kv1.2 was used as a control 
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for a fast-inactivating hetero-tetramer; its lack of Kv1.6 subunit results in the fastest 
inactivation kinetics in comparison with the other heteromers tested. 
 
3.6.2 Subunit ordering reveals position dependency of NIP function 
In this study, the subunit ordering and delivery of intact hetero-tetramers to the 
plasmalemma allowed the generation of channels that exhibit different types of inactivation 
by incorporating just one copy of Kv1.4 and 1.6, rather than two as examined previously 
(Roeper et al., 1998). Moreover, the concatenation of these subunits along with Kv1.2, 
combinations reported to coexist in the brain (Shamotienko et al., 1997), permitted 
elucidation of the importance of their ordering. The NIP in Kv1.6 proved functional only if 
placed immediately next to (position II or IV) its target Kv1.4 (position I) in the formed 
channel, yielding a slow-inactivating K+ current. Positioning Kv1.6 distal to Kv1.4 (position 
III) led to N-type fast inactivation, presumably because NIP is not optimally positioned to 
appropriately antagonize the activity of NIB. Furthermore, the same fast inactivation 
kinetics were observed with NIP mutated forms of these channels, confirming that only the 
NIP domain is responsible for counteracting the function of NIB. Such position dependency 
of NIP activity could accord with a previous suggestion (Roeper et al., 1998) that this 
domain does not act by occupying the acceptor site for NIB, instead, interacting directly 
with the latter. 
 
3.6.3 NIP, NIB and inactivation outcomes 
It was of interest to consider the observed inactivation profiles in relation to occupancy (or 
not) by NIB of its receptor site on the S6 segment of the channel, because this mechanism 
is the basis of N-type inactivation (Hoshi et al., 1990; Zagotta et al., 1990; Tseng-Crank et 
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al., 1993). A reported inability of expressed homo-tetrameric Kv1.6 channel (Stuhmer et al., 
1989; Roeper et al., 1998) to produce a fast-inactivating K+ current implies that its NIP 
moiety is unable to bind to the inner pore, at least in a blocking fashion. It is noteworthy 
that the observed rates of fast inactivation for the mutated adjacent and distal concatemers 
are similar, indicative of the positioning of a non-functional NIP domain not impacting on 
their fast inactivation. Moreover, the fast inactivation behaviour of Kv1.4–1.6(E27/30/32A)–
1.2–1.2 channels showed clearly that NIP and NIB domains are directly interacting upon 
depolarization, mainly by probable electrostatic interactions before the NIB reaches its 
receptor, by an undefined mechanism (Roeper et al., 1998). One can speculate that 
conformational changes, initiated by the activation process, would be sensed by both 
charged motifs of the NIP and NIB domains facilitating their interaction. Positioning of 
both domains away from each other would prevent such interaction, as seen with both 
Kv1.4–1.2–1.6(E27/30/32A)–1.2 and Kv1.4–1.2–1.6–1.2 channels. In situ hybridization and 
immuno-histochemical localization studies have suggested that Kv1.2, 1.4 and 1.6 proteins 
may coexist on the membranes of several types of central neurons in mammals (Veh et al., 
1995; Shamotienko et al., 1997; Chung et al., 2005; Kim et al., 2007; Lee et al., 2009). In 
rat brain membranes, hetero-multimeric Kv1 channels of Kv1.4 and 1.6 subunits were co-
immunoprecipitated using subunit-specific antibodies in immuno-affinity experiments 
(Shamotienko et al., 1997; Roeper et al., 1998). Collectively, these findings suggest that the 
gating contributions of Kv1.4 subunits can be modified by differential positioning of the 
NIP domain of Kv1.6 subunit in neuronal Kv1 channels. In co-expression studies, 
recombinant Kvβ1 has been shown to confer rapid inactivation, via its distinct NIB domain, 
on all tested members of Kv1α subunits except Kv1.6, suggesting that Kvβ1 subunit could 
also be an important modulator of K+ channel complexes (Rettig et al., 1994; Heinemann et 
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al., 1996). In fact, the Kv1.2, 1.4, and 1.6 α subunits in rat brain membranes can be co-
immuno-precipitated with Kvβ1 (Rhodes et al., 1997). These findings indicate that, in 
neurons, the gating of Kv1 heteromers can be modified by NIB/NIP domain(s) and/or 
auxiliary β1 subunits. In either case, the Kv1.6 subunit position in the heteromeric Kv1 
channel could play a key role in tuning the inactivation process and, thus, shaping the firing 
pattern of the neuron. It is tempting to speculate on the functional relevance of NIP action 
in diseased states. Seizure activity in an animal model has been linked to the spatio-
temporal changes in the expression of the Kv1 subfamily within the hippocampus (Lee et al., 
2009), where the levels of delayed rectifier Kv1 channels (including Kv1.2 and Kv1.6) are 
reduced with minor changes in Kv1.4. This curious alteration might be a physiological 
response to seizure events in which Kv1.4 inactivation by NIP gets diminished, thereby 
dampening unwanted depolarizations during attacks. Extensive investigations would have 
to be performed to assess the in vivo functional implications of NIP and its placement 
within native hetero-tetramers. 
 
It is clear from the results presented herein that: (a) concatenation of Kv1 subunits results in 
the predicted assembly of functional channels at the plasmalemma; (b) subunit ordering 
crucially influences channel properties; (c) stoichiometry alone is not sufficient for 
predicting the characteristics of native channels and (d) NIP–NIB interaction(s) occur at a 
site distinct from that of the NIB-binding site in the inner portion of the ion pore. 
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CHAPTER 4 
 
RESULTS 
 
Stiochiometry and positioning of α subunits influence the biophysical and 
pharmacological profiles of Kv1.1- and 1.2-containing channels 
 
4.1 Overview 
In Kv1 channels susceptible to blockade by TEA, all four subunits make an energetic 
contribution to binding a single TEA molecule at the extracellular mouth, where an 
aromatic residue in the pore-forming region is required for high sensitivity (MacKinnon 
and Yellen, 1990; Kavanaugh et al., 1991; Heginbotham and MacKinnon, 1992; 
Kavanaugh et al., 1992). TEA sensitivity is mainly due to the presence in Kv1.1 of the 
critical residue (Y379, Kavanaugh et al., 1991), whereas Kv1.2 homo-tetrameric channel 
that has valine (V381) at the equivalent location (Fig. 4.1) is only feebly inhibited by TEA. 
Even though the TEA sensitivity of adjacently- and diagonally-positioned Kv1.1 and 1.2 
subunits in Kv1 channels is different (Al-Sabi et al., 2010), earlier studies had deduced that 
only the stoichiometry of these α subunits and not their arrangement influences the 
susceptibility to TEA (Hurst et al., 1992; Shen et al., 1994). Clarification of this important 
question was sought herein by establishing if inhibition of K+ currents by TEA is affected 
by varying the number and position of sensitive Kv1 subunits tandem-linked within 
tetramers. This strategy allows pre-determination of not just the combinations of α subunits 
but, also, their actual arrangements in the channels trafficked to the plasmalemma (Al-Sabi 
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et al., 2010). As a major aim of this investigation was to establish the optional positioning 
within tetrameric channels of residues that contribute to TEA sensitivity, the tyrosine 
known to be essential in Kv1.1 was substituted initially into Kv1.2 at position 381 and/or 
together with a R354A mutation to make it more like the highly susceptible Kv1.1 subunit 
(Fig. 4.1). In the first instance, Kv1.1 and 1.2 homomeric channels were used for this 
purpose because concatenation has been shown not to alter their blockade by TEA (Al-Sabi 
et al., 2010). Further mutation(s) in selected pore-aligned residue(s) of the first Kv1.2 α 
subunit in Kv1.2-1.2-1.1-1.2 were introduced to evaluate their effects on the channels’ 
biophysical and pharmacological profiles.  
 
Fig. 4.1 Amino acid sequence alignment of turret, pore helix and filter regions of Kv1.1 and 1.2.  
Colour highlighted amino acids in Kv1.2 mutated to the highlighted sequence in Kv1.1.  
 
4.2 Pre-defined Kv1.1 and 1.2 α gene cassettes assembled into pIRES2-EGFP plasmid 
in position-specific arrangements  
Concatenation of Kv1 genes in a single open reading frame (ORF) was carried out to 
facilitate their expression as functional channels on the surface of HEK-293 for 
examination of their biophysical and pharmacological properties. Tetrameric constructs 
encoding Kv1.1-1.2-1.1-1.1, Kv1.2-1.2-1.1-1.1 and Kv1.2-1.2-1.1-1.2 (Fig. 4.2A and B) 
were engineered, using an inter-subunit linker derived from the Xenopus β-globin gene and 
paired restriction sites (Al-Sabi et al., 2010). Kv1.1-1.2-1.1-1.1 channel is expected to be 
TEA sensitive, as Kv1.1 subunits at position I and III should form a diagonal arrangement  
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Fig. 4.2 Overview of Kv1.1 and 1.2 concatenated tetrameric constructs used in this study, and sequential 
release of constituents from representative Kv1.X tetramers.  
(A) Concatenated constructs of Kv1 subunit genes in pre-defined positions predicted for the 
expressed proteins. (B) Tetrameric DNA constructs Kv1.1-1.2-1.1-1.1 (B1), Kv1.2-1.2-1.1-1.1 (B2), 
Kv1.2-1.2-1.1-1.2 (B3), Kv1.1-1.1-1.1-1.1 (B4) and Kv1.2-1.2-1.2-1.2 (B5) digested with position-
specific enzymes (NheI/BglII, BglII/EcoRI, EcoRI/SalI and SalI/BamHI) released Kv1.1 or Kv1.2 
subunits (∼1.5 Kb), along with the half-linkers and restriction enzyme sites (RES) as seen in the 
agarose (0.85%) gel electrophoretograms. EcoRV and SphI are unique RES in Kv1.2 or Kv1.1 
subunits, respectively and, thus, used to verify the presence of either Kv1.2 or Kv1.1 in tetrameric 
constructs. M, 1 Kb DNA ladder.  
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postulated to be preferential for high affinity TEA binding (Al-Sabi et al., 2010), with an 
additional Kv1.1 subunit in the fourth position. Addition of Kv1.2 to position I resulted in 
Kv1.2-1.2-1.1-1.1, a channel less sensitive to TEA as equal copies of Kv1.1 and 1.2 were 
placed adjacently (Al-Sabi et al., 2010). On the other hand, Kv1.2-1.2-1.1-1.2 channel (Fig. 
4.2A and B) was chosen because it shares with the latter identical subunits in the second 
and third positions, but having three copies of Kv1.2 that would be expected to make this 
channel relatively insensitive to TEA. Homo-tetrameric Kv1.1 and 1.2 channels were 
utilized as positive and negative controls, respectively. 
 
Desired position-specific alignment and orientation of Kv1 subunit gene(s) in all the 
constructs built herein were confirmed by restriction digestion with position-specific 
(NheI/BglII, BglII/EcoRI, EcoRI/SalI and SalI/BamHI) and gene-specific (EcoRV and 
SphI) restriction enzymes (Fig. 4.2B), respectively. In addition, correct nucleotide 
sequences of the constructs used in this study were confirmed by DNA sequencing. 
 
4.3 Characteristics of concatenated gene constructs expressed in HEK-293 cells 
HEK-293 cells were transiently-transfected with homo- or hetero-tetramers (Kv1.1-1.1-1.1-
1.1, Kv1.1-1.2-1.1-1.1 and Kv1.2-1.2-1.2-1.2), and surface biotinylated (c.f. Fig. 2.3; see 
Material and Methods) to establish that the channels were expressed and delivered to the 
plasma membrane  as concatenated intact protein. The analysis of cell lysates by SDS-
PAGE and Western blotting with subunit-specific antibodies Kv1.1 or 1.2 visualised 
proteins with Mr of ∼240 K (Fig. 4.3). This confirms that the concatenated strategy 
recombinantly built single chain homomeric or heteromeric channels as desired. 
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Fig. 4.3 Surface biotinylation of mammalian cells transfected with concatenated Kv1 channel α genes 
demonstrated expression on the cells surface of intact proteins with the expected size of tetramers.  
Transiently-transfected HEK-293 cells were surface biotinylated before being solubilized with 1% 
Triton X-100. Surface proteins were isolated from these lysates with streptavidin-agarose beads and 
run on SDS-PAGE (12%) acrylamide gel before being analyzed by Western blotting, using specific 
antibodies for Kv1.1 (lanes 1-4), or Kv1.2 (lane 6). Lanes: (1) non-transfected cells, (2) Kv1.1-1.1-
1.1-1.1 (3) Kv1.1-1.2-1.1-1.1, (4 and 6) Kv1.2-1.2-1.2-1.2. Protein markers are indicated in lanes 5 
and 7. 
 
4.4 Homomeric Kv1.2 channel is made susceptible to TEA by the V381Y mutation, yet 
a Kv1.1 tetramer is more sensitive to TEA  
Homomeric Kv1 channels comprising four copies of either Kv1.1, 1.2 or mutated forms of 
Kv1.2 subunits were evaluated for their TEA sensitivities compared with heteromeric 
channels made of different combination of these subunits. The homomeric Kv1.1 channel 
proved >300-fold more sensitive to TEA than its Kv1.2 counterpart, as shown by the dose-
response curves obtained by Qpatch recordings (Fig. 4.4) and corresponding IC50 values 
(Table 4.1). The latter accord with those reported for Kv1.1 and 1.2 homomers expressed in 
Xenopus and mammalian cells (Kavanaugh et al., 1991; Grissmer et al., 1994; Gutman et 
al., 2005).  
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Fig. 4.4 Delayed rectifier channel currents of wild-type and mutated monomeric Kv1.2.  
(A) Representative current traces from Kv1.2 homomeric channel and mutated form Kv1.2(V381Y) 
in the absence (black traces) and presence (grey traces) of 1 mM TEA. (B) Dose-response curves 
for the Kv1.2 homomeric (□) and Kv1.2(R354A) (△) channels display little inhibition whereas 
Kv1.2(V381Y) (■), Kv1.2(V381Y/R354A) (▲)  and Kv1.1 homomer (○) show increasing 
susceptibility to TEA. Some of the error bars fall within the data points. (n = 4-7). 
 
TEA susceptibility of the Kv1.2 channel was enhanced greatly when valine 381 is replaced 
by tyrosine [(Kv1.2(V381Y)); for position of the mutation, see Fig.4.5, and Fig. 4.6] as 
revealed in representative current traces (Fig. 4.4A) and TEA dose-response curves (Fig. 
4.4B), with the difference in sensitivity being reduced to 2-fold compared to Kv1.1 (Table 
4.1).  
 
Table 4.1 IC50 values for TEA inhibition of wild-type and mutated forms of 
homomeric Kv1.1 and 1.2 channels expressed in HEK-293 cells 
Kv1.2 Kv1.2 
(R354A) 
Kv1.2 
(R354A/V381Y) 
Kv1.2 
(V381Y) 
Kv1.1 Channel 
>100 
(7) 
>100 
(4) 
*0.87 ± 0.16 
(4) 
*0.8 ± 0.04 
(6) 
0.35 ± 0.02 
(5) 
IC50 
[mM] 
Results are means + S.E.M., n replicates are in parenthesis. * P < 0.01 values are significant 
compared to Kv1.1 (unpaired Student’s t-test). 
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As the TEA sensitivity of Kv1.2(V381Y) channel does not exactly match that of Kv1.1 
homomer (Table 4.1, P < 0.01 unpaired t-test), this might be due to the effect of other pore 
residues that differ between Kv1.1 and 1.2. Nevertheless, Kv1.2(R354A) channel showed 
unaltered insensitivity, comparable to that of Kv1.2 (Fig. 4.4, Table 4.1); moreover, when 
that mutation was combined with V381Y [Kv1.2(R354A/V381Y)], it gave a TEA value similar to 
that of the  Kv1.2(V381Y) channel (Table 4.1); thus, Kv1.2(R354A) mutation alone was excluded 
from further study herein, though it should be noted that this residue affects the binding of 
peptide toxin blockers (Visan et al., 2004). 
 
Fig. 4.5 Nucleotide sequencing shows the expected change of encoded amino acids resulting from 
mutations introduced in Kv1.2 gene.  
Wild type monomeric Kv1.2 subunit (A) was mutated in the pore-region using site-directed 
mutagenesis and cloned into expression vector (pIRES2-EGFP) to generate mutated Kv1.2 channel 
subunits - (valine 381 to tyrosine - Kv1.2(V381Y) (B) and arginine 354 to alanine - Kv1.2(R354A) 
(C). Position I specific Kv1.2 subunit carrying mutation (V381Y) was incorporated into tetrameric 
constructs containing Kv1.1/1.2 subunits (Fig. 4.6). Sequences: Top line is amino acid sequence 
(numbering was given according to the published mRNA sequence). Middle (sense strand) and 
bottom (anti-sense strand) lines are of nucleotide sequences (numbering was generated by the 
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sequencer during sequencing). A distinct colour was assigned to each nucleotide to identify their 
representative traces during sequencing. 
 
The information acquired at this stage provided a logical basis for using the Kv1.1 and 1.2 
genes to build the hetero-tetramers of different combinations and to introduce selected 
mutants of Kv1.2 at the first position in some variants, with the purpose of ascertaining the 
effects of positioning of these subunits and mutants on the channels’ overall sensitivity to 
TEA. 
 
4.5 Different compositions of Kv1.1/1.2-containing heteromers give IK with distinct 
voltage-dependence of activation kinetics 
Kv1 heteromers were generated and their voltage-dependencies of activation were 
examined by conventional whole-cell patch-clamp recordings, after HEK-293 cells had 
been transfected separately with concatenated constructs built from different combinations 
of Kv1.1 and 1.2 subunits. As sequence alignment of the pore regions shows these 
monomers to be highly conserved, except in particular locations at the turret region and 
nearby the selectivity filter (see Fig. 4.1), selected mutation(s) (Fig. 4.6) were introduced at 
the first position of Kv1.2-1.2-1.1-1.2 channel and their influences on conductance-voltage 
relationship (gK-V) examined (Fig. 4.7). All these Kv1 concatemers showed delayed 
rectifying outward Kv currents (IK) when subjected to a depolarizing voltage step; 
representatives are displayed in Fig. 4.7A. The gK-V profile of each concatenated hetero-
tetrameric channel could be well fitted by a single Boltzmann function (Fig. 4.7B).  
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Fig. 4.6 Created Kv1.1/1.2-containing channels varying in stoichiometry carried mutation (s) in Kv1.2 
cloned at first position of a tetramer.  
(A) Schematic of predicted expressed proteins with mutant Kv1.2 subunit in a tetramer (B) 
NheI/BglII, BglII/EcoRI, EcoRI/SalI and SalI/BamHI digested Kv1.1/1.2 constructs containing 
Kv1.2 mutant subunit: Kv1.2(V381Y)-1.2-1.1-1.1 (B1), Kv1.2(V381Y)-1.2-1.1-1.2 (B2) and 
Kv1.2(Q357H/P359S/V381Y)-1.2-1.1-1.2 (B3) released position-specific subunits. Kv1.1 and 1.2 
subunits were verified by gene-specific enzymes SphI and EcoRV, respectively. As seen in agarose 
(0.85%) gel electrophoretogram, a band at ∼1.5 Kb represents the Kv1.1 or 1.2 gene along with 
half-linkers and restriction enzyme sites. M, 1 Kb DNA ladder. (C) DNA sequencing confirmed the 
mutation of turret region amino acids, glutamine 357 and proline 359 of Kv1.2 to histidine and 
serine, respectively. Sequences: Top line is amino acid sequence (numbering was given according 
to the published mRNA sequence). Middle (sense strand) and bottom (anti-sense strand) lines are of 
nucleotide sequences (numbering was generated by the sequencer). A distinct colour was assigned 
to each nucleotide to aid their identification. 
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As predicted, concatenated homo-tetrameric Kv1.1 channel yielded a IK current with the 
most negative V1/2 value (Table 4.2), which is indistinguishable from its non-concatenated 
counterpart (V1/2 = -30 ± 1, n = 13; Al-Sabi et al., 2010). On the other hand, concatenated 
Kv1.2 channel activated at more depolarised potentials and revealed, as expected, the most 
positive V1/2 value (Table 4.2), similar to the value for homomeric Kv1.2 channel (V1/2 = -2 
± 1, n = 7). This indicates that the concatenation did not affect the voltage-dependence of 
activation of the tetrameric channels tested, for homo-tetramers at least. Previously, 
heteromeric channels with similar composition but different subunit positioning (Kv1.2-1.2-
1.1-1.1 and Kv1.1-1.2-1.1-1.2) were found to have similar biophysical characteristics (Al-
Sabi et al., 2010), albeit different V1/2 values (Table 4.2).  
 
A
Kv1.2(Q357H/P359S/V381Y)-1.2-1.1-1.2
100 ms
Kv1.1-1.2-1.1-1.1
2 nA
Kv1.2(V381Y)-1.2-1.1-1.2
5 nA
Kv1.1-1.1-1.1-1.1 Kv1.2-1.2-1.2-1.2
1 nA 5 nA
5 nA
Kv1.2-1.2-1.1-1.2
5 nA
B
Voltage (mV)
G
/G
m
ax
1.0
0.5
0.0
-80 -40 0 40 80
 
Fig. 4.7 Biophysical profiles of tetramers distinct in their subunit composition.  
(A) Representative current traces recorded from transfected HEK-293 cells by conventional patch-
clamp, in response to depolarising steps from -80 to 80 mV in 10 mV increments. (B) Conductance-
voltage relationship of the steady state currents calculated from -82 mV reversal potential after 200 
ms at indicated voltages; Boltzmann fits of the data for concatenated homomeric Kv1.1 (○) and 
Kv1.2 (□), Kv1.1-1.2-1.1-1.1 (●), Kv1.2-1.2-1.1-1.2 (■), Kv1.2(V381Y)1.2-1.1-1.2 (△) and Kv1.2 
(Q357H/P359S/V381Y)-1.2-1.1-1.2 (▽) channels. Some of the error bars fall within the data points. 
(n = 4-7). 
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The 3 copies of Kv1.1 subunits in Kv1.1-1.2-1.1-1.1 shifted the channel’s V1/2 toward less 
negative potentials than Kv1.1 channel (Fig. 4.7B, Table 4.2); likewise even one copy of 
Kv1.2 in Kv1.1-1.2-1.1-1.1 is enough to exert such a shift in V1/2 from that of Kv1.1-1.1-1.1-
1.1 concatemer (P < 0.001, Mann-Whitney U test, Table 4.2). 
 
However, Kv1.2-1.2-1.1-1.1 with 2 copies of each subunit showed a further but not 
significant shift in V1/2 value compared to Kv1.1-1.2-1.1-1.1. Three Kv1.2 subunits in 
Kv1.2-1.2-1.1-1.2 channel produced a IK current with a V1/2 close to the value of tandem-
linked Kv1.2-1.2-1.2-1.2 (Fig. 4.7B, Table 4.2); hence, one copy of Kv1.1 in the tetramer 
causes just a minor shift in V1/2 from that of Kv1.2-1.2-1.2-1.2. Hence, the shifts in V1/2 
values observed are directly influenced by the number of identical subunits in the tetramers. 
 
Table 4.2 Votage-dependace of activation of Kv1 concatanated heteromers and 
mutants compared with their tandem-linked parental homomers 
Parameter Kv(1.1)4 Kv1.1-1.2-
1.1-1.1 
Kv1.1-1.2-
1.1-1.2 
Kv1.2-1.2-
1.1-1.1 
Kv1.2-1.2-
1.1-1.2 
Kv1.2(V351Y)-
1.2-1.1-1.2 
Kv1.2(Q357H/P359
S/V351Y)
-1.2-1.1-
1.2 
Kv(1.2)4 
V1/2  -32 
 ± 1 
*-20  
± 1 
†*-22 ± 
1 
†*-18 ± 
1 
*-2  
± 1 
*-4 
 ± 2 
*-3 
 ± 1 
*-1 
 ± 1 
k  (mV) 12 ± 1  
(5) 
16 ± 1 
(4) 
11 ± 1 
(7) 
12 ± 1 
(14) 
17 ± 1 
(4) 
20 ± 2  
(5) 
21 ± 1  
(5) 
19 ± 1  
(5) 
Results are represented as means + S.E.M., n replicates are in parenthesis. *P < 0.001 values are 
significant compared to Kv(1.1)4 (Mann-Whitney U test). † Data taken from Al-Sabi et al., 2010. 
 
In contrast, tetramers having the same subunit compositions and positioning (Kv1.2-1.2-
1.1-1.2) but with a selected pore mutation (Kv1.2(V381Y)-1.2-1.1-1.2) (Fig. 4.6A and B) gave 
a similar V1/2, close to that for homomeric Kv1.2-1.2-1.2-1.2 channel (Fig. 4.7A and B). 
Additional mutations at the turret region of that channel arrangement 
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(Kv1.2(Q357H/P359S/V381Y)-1.2-1.1-1.2) (Table 4.2) failed to significantly shift the V1/2 
compared to that of the wild-type, apparently because these mutations are not involved in 
the gating of this Kv1 channel. 
Clearly, these results indicated that subunit composition of these concatenated channels 
affects their biophysical properties, namely the voltage-dependence of activation. 
 
4.6 TEA sensitivities of Kv1 concatemeric channels are affected by altering their 
subunit composition or introducing a selective pore mutation 
While tandem-linked homo-tetrameric Kv1.1 channel showed similar TEA sensitivity to 
their homomeric counterparts (Fig. 4.8A, Table 4.1 and 4.3), replacing one of its subunits 
with an insensitive Kv1.2 constituent to produce Kv1.1-1.2-1.1-1.1 resulted in a significant 
3-fold drop in TEA sensitivity  (IC50) compared to that of Kv1.1-1.1-1.1-1.1 (Fig. 4.8A and 
B, Table 4.3, P < 0.01, un-paired t-test).   
 
 
Fig. 4.8 Current traces of Kv1.1/1.2-containing hetero-tetrameric channels in the absence or presence of 
TEA.  
(A) Representative current traces from QPatch recordings in the absence (black traces) and presence 
(grey traces) of 1 mM TEA. (B) Dose-response curves for Kv1.2-1.2-1.2-1.2 (□), Kv1.1-1.2-1.1-1.1 
(●), Kv1.2(V381Y)-1.2-1.1-1.1 (■) and Kv1.1-1.1-1.1-1.1(○) in order of increase susceptibility to 
TEA. Some of the error bars fall within the data points. (n = 5-8). 
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A similar shift in TEA susceptibility could be achieved by mutating the first insensitive 
subunit, Kv1.2(V381Y)-1.2-1.1-1.1 (Fig. 4.8A and B, Table 4.3), with an IC50 of ~1 mM. 
Furthermore, Kv1.2-1.2-1.1-1.2, with a single Kv1.1 subunit at the third position gave a IK 
current insensitive to TEA (Fig. 4.10A); its IC50 was indistinguishable from that of Kv1.2-
1.2-1.2-1.2 channel (Fig. 4.8, Table 4.3), indicating that one copy of Kv1.1 subunit is 
insufficient for TEA co-operative binding.  
 
Table 4.3 IC50 values for inhibition by TEA of wild-type and mutated forms of Kv1 
concatenated tetramers 
Channel  IC50 [mM]  
Kv1.1-1.1-1.1-1.1  0.39  ±  0.1 (8) 
Kv1.1-1.2-1.1-1.1  *1.1  ±  0.1 (6) 
§
Kv1.1-1.2-1.1-1.2 *0.9  ±  0.1 (8) 
§
Kv1.2-1.2-1.1-1.1  8  ±  1 (4) 
Kv1.2-1.2-1.1-1.2  > 100 (4) 
Kv1.2-1.2-1.2-1.2 > 100 (7) 
Kv1.2
(V381Y)
-1.2-1.1-1.1  *0.9  ±  0.1 (5) 
Kv1.2
(V381Y)
-1.2-1.1-1.2  > 100 (4) 
Kv1.2
(V381Y)
-1.2-1.2-1.1  9  ±  1 (6) 
Kv1.2
(Q357H/V381Y)
-1.2-1.1-1.2  > 100 (4) 
Kv1.2
(Q357H/P359S/V381Y)
-1.2-1.1-1.2  > 100 (5) 
Results are represented as means + S.E.M., n replicates are in parenthesis. * (P < 0.01) values are 
significant compared to Kv1.1-1.1-1.1-1.1, (unpaired Student’s t-test); § data are taken from (Al-
Sabi et al., 2010) for comparison. 
 
Collectively, these results indicate that the pharmacological profile of Kv1 tetramers can be 
altered by changing the stoichiometry of subunits (e.g. by increasing the number of TEA 
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sensitive subunits) or by selected mutation of Kv1.2 in the first position of certain 
heteromers. 
 
4.7 Mutating a Kv1.2 in its pore region does not induce TEA sensitivity into Kv1.2-1.2-
1.1-1.2 unless the Kv1.1 is arranged adjacently to the mutated Kv1.2  
In the next experiments, the stoichiometry of the subunits was kept equal with the first 
subunit mutated to Kv1.2(V381Y) in the expectation of increasing the channel’s susceptiblity 
to TEA [i.e. to that of the diagonally-arranged (Kv1.1-1.2-1.1-1.2) channel reported 
previously (Al-Sabi et al., 2010) (see Table 4.3)]. Surprisingly, the IK produced by 
Kv1.2(V381Y)-1.2-1.1-1.2 channel proved to be TEA-insensitive (IC50 > 100) and, therefore, 
remained similar to its wild-type (Fig. 4.10A and B, Table 4.3).  
 
 
Fig. 4.9 Restriction digestions showing the subunits released from the mutated hetero-tetrameric DNA 
construct.  
Kv1.2(V381Y)-1.2-1.2-1.1 gene construct was made by positioning Kv1.1 gene adjacent to 
Kv1.2(V381Y) nucleotide sequence. Positioning of Kv1.1 and 1.2 genes in the concatemer were 
confirmed by position-specific and gene-specific enzyme digestion followed by agarose gel 
electrophoresis. A band at ∼1.5 Kb represents the Kv1.1 or Kv1.2 gene along with half-linkers and 
restriction enzyme sites. M, 1 Kb DNA ladder. 
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This unexpected observation was further investigated by inserting additional mutations, 
resembling their equivalents in Kv1.1 subunit at the turret region (see Fig. 4.1), 
Kv1.2(Q357H/V381Y)-1.2-1.1-1.2 and Kv1.2(Q357H/P359S/V381Y)-1.2-1.1-1.2, but these also gave IK 
currents resistant to TEA (Table 4.2).  
 
 
Fig. 4.10 Variation in sensitivity to TEA is revealed from the K+ currents observed for mutated Kv1.2 
channels.  
(A) Current traces recorded using QPatch from the wild-type and variant channels in the absence 
(black traces) and presence (grey traces) of 10 mM TEA. (B) Dose-response curves for the Kv1.2-
1.2-1.1-1.2 (▲) and its mutant Kv1.2(V381Y)-1.2-1.1-1.2 (△) channel show similar TEA 
insensitivity (IC50 > 100; B, left panel). Dose-inhibition plot for the additional mutated form 
Kv1.2(V381Y)-1.2-1.2-1.1 (□) (B, right panel reveals increased susceptibility; IC50 = 9+1). Some of 
the error bars fall within the data points. (n = 4-6). 
 
However, a TEA-sensitive IK current resulted (Fig. 4.10A) from swapping Kv1.1 and 1.2 
subunit in the third and fourth position of Kv1.2(V381Y)-1.2-1.1-1.2 channel to produce a 
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channel retaining the same stoichiometry but with a Kv1.1 subunit in close proximity or 
adjacent (when assembled) to the mutated-sensitive Kv1.2 [Kv1.2(V381Y)-1.2-1.2-1.1 channel 
(Fig. 4.9)]. Its IC50 approximated to the channel having two copies of sensitive subunit in 
an adjacent arrangement [i.e. Kv1.2-1.2-1.1-1.1 channel] (Table 4.3). Hence, with the 
channels’ subunit stoichiometries maintained, the positioning of sensitive subunits 
modulates the extent of their susceptibility to inhibition of their IK by TEA. 
 
4.8 Kv1.1 subunits lower the activation threshold and speed-up activation kinetics of 
Kv1 channels recombinantly expressed in mammalian cells 
To examine how demyelination-associated enrichment of Kv1 channels with Kv1.1 subunit 
could affect their functional properties, biophysical profiles of the currents mediated by 
concatenated homo-Kv(1.1)4 or Kv(1.2)4 and hetero-tetramers (Kv1.1-1.2-1.1-1.1, Kv1.1-
1.1-1.2-1.2) were analyzed. Each mediated voltage-activated non-inactivating K+ currents, 
which were consistently larger in cells expressing Kv1.2 homo-tetramers or those 
containing this subunit together with Kv1.1 (Fig. 4.11 C1-E1). Most importantly, Kv1.1 
homo-tetrameric channels activated at less depolarized thresholds than the currents 
resulting from the others (Bagachi et al., 2014). This feature is reflected clearly in 
conductance-voltage (gK-V) plot of the K+ currents, with Kv(1.1)4 activating from 
significantly more hyperpolarized potentials (close to -60 mV) compared to the Kv1.1-1.2-
1.1-1.1, Kv1.1-1.1-1.2-1.2 and Kv(1.2)4 channels (Fig. 4.11 C2-E2, Table 4.4). In all cells, 
the gK-V relationships of the K+ currents were fitted well with a Boltzmann function with 
half-maximal values of activation (V1/2) for Kv(1.1)4 being most negative followed by 
intermediate potentials for the currents mediated by Kv1.1-1.2-1.1-1.1 or Kv1.1-1.1-1.2-1.2, 
and the most depolarized values observed with Kv(1.2)4 channels (Table 4.4). 
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Fig. 4.11 Functional characterization of recombinant Kv1.1 homo-tetramers reveals distinctive 
biophysical profiles from those of Kv1.1/1.2 hetero-tetramers.  
(A, C1–E1) Representative recordings of macroscopic currents (300 ms pulse) from HEK-293 cells 
transfected with the individual recombinant channels. (A, B) Activation rate of the voltage-
dependent K+ currents mediated by Kv(1.1)4 (left) and Kv(1.2)4 (middle) channels (within the range 
of 10–30% of max. current) at 5 mV from indicated voltages (below) with super-imposed (right) 
representative traces from. A notable difference between the rates of activation of Kv(1.1)4 and 
Kv(1.2)4 is revealed by fitting the data with a single exponential (see B). (C2–E2) Conductance-
voltage relations of macroscopic currents measured, based on the K+ current of the last 100 ms for 
each channel. Conductance at various command potentials were normalized and fitted with a single 
Boltzmann function. The difference in conductance values of Kv(1.1)4 and Kv(1.2)4 channel were 
statistically significant from 255 mV (P, 0.05, Mann-Whitney U test, see Table 4.4 for summary of 
the biophysical data). (n = 6-10). 
 
Interestingly, significant differences were also observed between activation rates of these 
currents at near-threshold potentials, with Kv(1.1)4 channel displaying a faster activation 
rate than the others (Fig. 4.11 A and B, C; Table 4.4). 
 
 
C 
A B 
C1 D1 E1 
C2 D2 E2 
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Table 4.4 V1/2 for activation and onset rate of currents mediated by the different 
recombinant channels expressed in HEK-293 cells 
Parameters Kv(1.1)4 Kv1.1-1.2-1.1-1.1 Kv1.1-1.2-1.2-1.2 Kv(1.2)4 
V1/2 (mV) -35 + 1 (6) **-20 + 1 (10) #**-17 + 1 (9) **-7 + 1 (8) 
tau1/2 (ms) 13 + 2 (6) *18 + 1 (8) **24 + 1 (8) **29 + 2 (8) 
Results are represented as means + S.E.M. (n-values); * (P < 0.05) and ** (P < 0.005) numbers are 
significant compared to those from Kv(1.1)4, (Mann Whitney U test); # data are taken from Al-Sabi 
et al., 2010. 
 
4.9 Kv1.1- and Kv1.2-containing channels can be distinguished by selective blockers  
HEK-293 cells expressing channels composed of homo-tetrameric Kv(1.1)4, (1.2)4 or 
hetero-tetrameric combinations of both subunits [Kv1.1-1.2-1.1-1.1 and [Kv(1.1)2-Kv(1.2)2] 
were used to mimic those possibly present in demyelinated optic nerve (ON) axons. DTXK 
potently and selectively inhibited only the Kv1.1 homo-tetrameric channels, with sub-
nanomolar IC50 (Table 4.5); introduction of a single Kv1.2 subunit into the tetramer (Kv1.1-
1.2-1.1-1.1) lowered its susceptibility to blockade by DTXK. Having two copies of Kv1.2 
and Kv1.1 subunits in the concatamer (Kv1.1-1.1-1.2-1.2), resulted in an even lower 
sensitivity to DTXK (IC50 > 100 nM). On the other hand, Kv(1.2)4 channel was blocked by 
TsTX-Kα but apparently insensitive to DTXK (Table 4.5). The K+ current elicited by a 
heteromeric channel with equal numbers of Kv1.1 and 1.2 subunits proved, 6 -fold less 
sensitive to TsTX-Kα than Kv(1.2)4. Furthermore, TsTX-Kα blockade was insignificant on 
Kv1 channels containing 3 or 4 copies of Kv1.1 subunits. Collectively, these results showed 
that DTXK and TsTX-Kα are potent inhibitors of Kv1 channels that contain at least three 
copies of Kv1.1 and two copies of 1.2 subunits, respectively. 
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Table 4.5 Differential inhibition of concatenated Kv1 channels expressed in HEK-293 
cells by DTXK and TsTX-Kα 
Kv1 channels IC50 (nM) 
DTXK TsTX-Kα 
Kv(1.1)4 0.27 ± 0.07 (5) >100 (3)# 
Kv1.1-1.2-1.1-1.1 *4 ± 0.1 (4) >100 (3) 
Kv1.1-1.2-1.2-1.2 >100 (4) 15 ± 2 (4)# 
Kv(1.2)4 >100 (3) 2.6 ± 0.2 (3)# 
Results are represented as means + S.E.M.; n-values are in brackets; * (P < 0.05) numbers are 
significant compared to Kv(1.1)4 (t-test), # data were taken from Al-Sabi et al., 2010. 
 
4.9 Discussion 
 
4.9.1 Tetrameric Kv1 channels composed of pre-determined subunit combinations exhibit 
distinct functional characteristics 
An innovative cloning platform was employed herein that affords expression of four α 
subunits as a single protein, with pre-determined compositions and positions of subunits as 
functional channels on the plasmalemma. This technology confines channel assembly to a 
proscribed order and paved the way for studying Kv1 heteromers of defined stoichiometry. 
Studies focused on Kv1.1-1.2-1.1-1.1 and Kv1.2-1.2-1.1-1.2 or variants thereof. These two 
heteromeric channels showed distinct gK-V plots fitted well by single-Boltzmann 
distribution, predictable profiles toward TEA reflective of their different subunit 
compositions; importantly, such distinctive characteristics are indicative of uniform single-
type channel populations. In addition, concatenated homo-oligomers of Kv1.1 or 1.2 were 
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made as control channels; importantly, these proved indistinguishable from their respective 
homomeric counterparts, demonstrating that tandem linkage does not alter their properties, 
in accord with other earlier findings (Sokolov et al., 2007; Al-Sabi et al., 2010). Notably, 
gradual changes were observed in both the biophysical properties (e.g.: gK-V relationship) 
and TEA sensitivity upon altering the ratio of Kv1.1 to Kv1.2 subunits in tetramers 
indicating that hybrid channels containing mixtures of Kv1.1 and 1.2 exhibit intermediate 
phenotypes being a blend of those of the parental channels.  
 
4.9.2 Positioning of α subunits and those possessing a key tyrosine profoundly affects 
TEA inhibition of the K+ currents  
As predicted, mutating Kv1.2 in the first position in Kv1.2(V381Y)-1.2-1.1-1.1 construct 
yielded a channel having ~ 9-fold higher  TEA sensitivity, similar to that of Kv1.1-1.2-1.1-
1.1 (Table 4.3). This improved TEA susceptibility is presumably due to the presence of 2 
copies of Kv1.1 subunits that cooperatively interact with TEA in addition to the 
contribution of another sensitive subunit, Kv1.2(V381Y) mutant, at the first position, while 
Kv1.2 occupied the second position in both channels. However, replacing the first position 
of the other standard concatemers, Kv1.2-1-2.1.1-1.2 with Kv1.2(V381Y), Kv1.2(Q357H/V381Y) or 
Kv1.2(Q357H/P359S/V381Y) did not improve inhibition of their K+ currents by TEA (Table 4.3). 
One explanation could be attributed to a repulsive effect from the two adjacent Kv1.2 
subunits (in the second and fourth positions) which might prevent interaction of 
Kv1.2(V381Y) subunit with TEA, and that turret region mutations added to the latter do not 
alter the channel’s overall sensitivity. The postulated repulsion was absent when Kv1.2 
subunit at the fourth position was replaced with Kv1.1; this channel (Kv1.2(V381Y)-1.2-1.1-
1.1) displayed a 100-fold enhanced TEA sensitivity (Table 4.3). A more modest change 
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could be achieved by keeping the same composition of the channel (Kv1.2(V381Y)-1-2.1.1-
1.2) but repositioning the sensitive Kv1.1 to be adjacent to the mutated sensitive subunit, as 
in Kv1.2(V381Y)-1.2-1.2-1.1 channel (Table 4.3). 
 
It seems that the higher affinity binding of the TEA (in case of homomeric Kv1.1 or its 
concatenated form) is achieved by simultaneously binding four aromatic side chains, one 
from each subunit through cation-π cooperative interaction (Hurst et al., 1992; Kavanaugh 
et al., 1992; Ahern et al., 2009). The insensitivity of Kv1.2(V381Y)-1.2-1.1-1.2 channel might 
arise from the binding of TEA being perturbed by valine 381 from the two wild-type Kv1.2 
subunits, and/or its three threonine 383 residues that differ from Kv1.1 and reside very close 
to the essential tyrosine 379. Accordingly, Kavanaugh et al. (Kavanaugh et al., 1992) 
showed that Kv1.1(Y379V) homomer was 30-fold less sensitive to TEA than wild-type and 
became completely insensitive when an additional mutation was introduced 
(Kv1.1(Y379V/V381T)). These observations can be related to the difference in TEA sensitivities 
observed herein between concatemers of Kv1.1 and Kv1.2(V381Y); threonine 383 in 
Kv1.2(V381Y) could be responsible for the ~2-fold lower sensitivity compared to that of Kv1.1 
homomer. Likewise, Kv1.1 subunit at the third position in Kv1.2(V381Y)-1.2-1.1-1.2 channel 
likely failed to endow TEA sensitivity  because 3 copies of non-permissive threonine 383 
and 2 of valine 381 are provided by the surrounding Kv1.2 subunits. However, in 
Kv1.2(V381Y)-1.2-1.2-1.1 channel, the Kv1.1 subunit at the fourth position was, apparently, 
free to bind TEA without the negative effect of threonine 383-containing subunits  along 
with the adjacent Kv1.2(V381Y), thereby, giving moderate TEA sensitivity (IC50 = 9 mM) 
similar to Kv1.2-1.2-1.1-1.1 channel.   
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4.9.3 Pharmacological research prospective for Kv1 channel concatemers 
Although Kv1 channels are expressed broadly throughout many regions of the CNS, their 
differential expression facilitates the appropriate modulation of neurotransmission. Kv1.1 
and 1.2 are localized along axons, as dense clusters in juxta-paranodal regions of 
myelinated nerves, and other subcellular compartments. They form hetero-tetramers of 
varying composition to support fast axonal repolarization and rapid conduction of high 
frequency AP (Wang et al., 1993; Rhodes et al., 1995; Wang et al., 1995). Hence, Kv1.1- 
and 1.2-containing channels in these axons modulate AP propagation and dampen 
unwanted repetitive firing (Wang et al., 1994; Ogawa et al., 2010). This might be achieved 
by formation of oligomeric subtypes of channels with different heteromeric combinations 
of subunits to achieve biophysical properties best tailored for particular functions. In this 
context, Robbins and Tempel (2012) have suggested that heteromeric assembly of Kv1.1 
and 1.2 subunits that varies between cell types and locations in CNS could be a reason why 
Kv1.1 or 1.2 null mice display spontaneous seizures though with distinct phenotypes. 
Recent observation in Kv1.1+/+ mice revealed that K+ channels composed of Kv1.1 in juxta-
paranodal regions dampen excitability in motor nerves during fatigue or ischemic insult 
(Brunetti et al., 2012). These collective findings highlight that recombinant forms of 
heteromeric Kv1.1 and 1.2 could provide relevant targets for drug research and 
development. Accordingly, Kv1.1-1.2-1.2-1.2 channel was used recently as a target for 
high-throughput screening of selective inhibitors (Wacker et al., 2012). This promising 
venture should impact on searches for potent and selective blockers of neuronal Kv1 
heteromers. 
 
91 
 
4.9.4 Implications for MS and other demyelinating disorders of the central nervous 
system 
A well-established molecular mechanism for stabilizing the membrane potential of 
demyelinated axons is provided by Na+/K+ ATPase which, due to its electrogenic nature, 
provides a persistent hyperpolarizing drive during sustained activity, moving the axonal 
membrane potential away from the firing threshold (Bostock and Grafe, 1985). An over-
expression of K+ channels enriched with Kv1.1 subunits in the ON axons from cuprizone-
fed mice provides another, perhaps, equally powerful means for stabilizing the membrane 
potential at sub-threshold voltages. Unlike genetic knock-down of Kv1.2 subunit (the main 
partner of Kv1.1) associated with reduced excitability of central neurons (Brew et al., 
2007), Kv1.1 null mutants exhibit hyper-excitability and augmented axonal conductivity 
(Smart et al., 1998; Brew et al., 2003), suggesting a powerful dampening influence of 
Kv1.1-concatenating channels on neuronal responsiveness. Assessment of the K+ current 
mediated by recombinant (Kv1.1)4 homo-tetrameric channels in HEK-293 cells revealed a 
lower activation threshold and faster kinetics than those recorded for (Kv1.2)4 homo-
tetramers or Kv1.2 subunit-containing hetero-tetramers. Indeed, the faster activation from 
more negative potentials of the K+ current mediated by Kv1.1 subunit-dominated channels 
in HEK-293 cells could restrain and stabilize the axonal membrane at sub-threshold 
potentials. Considering the selective increase and ectopic expression of Kv1.1 subunit in 
axons of demyelinated ON in relation to restoration of conductivity by DTXK point to this 
being a potential target for ameliorative interventions. The sparse information available on 
specific molecular alterations responsible for impaired conductivity of demyelinated axons 
along with the poor selectivity of small Kv channel blockers with their considerable adverse 
effects have greatly hampered the development of effective restorative means. Interference 
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of 4-AP, one of the most promising candidates, with remyelination and regeneration of 
impaired oligodendrocytes (Bacia et al., 2004) renders its clinical use for rescuing axonal 
conductivity problematic; this stresses the urgent need for identification and evaluation of 
novel drug candidates. Hence, the recognition herein of novel Kv1 channels enriched with 
Kv1.1 subunit represent a significant step forward towards the development of a specific 
extra-cellular blocker of such channels with potential for recovering the conductivity of 
demyelinated axons. 
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CHAPTER 5 
 
RESULTS 
 
Screening of various dipyromethanes compounds using recombinantly 
expressed Kv1.X channels, identified a novel and selective inhibitor for 
Kv1.1 channels  
 
5.1 Overview 
Kv1 channels, exposed upon demyelination of axons in patients suffering from MS, 
contribute to abnormal propagation of nerve signals and resultant debilitating muscle 
weakness. Although aminopyridines can inhibit the Kv1 channels, such therapy is only 
beneficial in the short-term; also, their blockade of other K+ channel types results in serious 
off-target effects, including seizures (Judge and Bever Jr., 2006). The observation of Kv1.1-
containing channels being expressed ectopically in ON demyelinated axons from mice fed 
cuprizone (Bagchi et al., 2014), mimicking changes in MS, has given an indication of the 
responsible subtypes; furthermore, the abnormal conductivity induced could be near-
normalised by attenuating the Kv1.1-mediated currents with DTXK, a selective blocker 
(Robertson et al., 1996). Thus, Kv1.1 is a promising target for extracellular inhibitors to 
potentially ameliorate such symptoms in demyelinated conditions like MS. In search of low 
molecular weight blockers, Kv1.1- and 1.2-containing concatenated tetramers, 
recombinantly built with a designed platform (Al-Sabi et al., 2010; Chapter 4) were utilized 
to screen small molecule inhibitors for their selectivity to block the Kv1 channels. 
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5.2 Rational design of a new selective inhibitor of Kv1.1 channels 
For designing selective blockers, their size and phobicity are vital criteria because if made 
too small, they would enter deep into the inner pore region of the K+ channel and, similar to 
4-aminopyridine, selectivity would be lost. We recently reported the activity of various 
substituted porphyrin derivatives as potent and selective blockers of neuronal Kv1 channels 
(Daly et al., 2015). Unfortunately, due to their phototoxicity and high molecular weights, 
the porphyrins are non-ideal candidates for the treatment of neuronal diseases. However, by 
using results from their structure-activity analysis, in combination with molecular 
modelling performed by Dr. G. K. Kinsella (Dublin Institute of Technology, Ireland), 
valuable pharmacophore information was realised that can be applied to develop a more 
suitable lead structure. To aid their design, a homology model of rat Kv1.1 tetramer was 
developed for molecular docking, based on the crystallographic structure of the mammalian 
closely-related Kv1.2 (Long et al., 2005). In this regard, it is noteworthy that symmetrically-
substituted porphyrins bearing alkyl amino groups (cationic-charged at physiological pH) 
can tightly bind a KcsA-Kv1.3 channel (Ader et al., 2008, Gradl et al., 2003). The goal was 
to rationally design an inhibitor which is 1) large enough to avoid entering the deep inner 
pore region of the Kv channels, 2) target the essential amino acid residues in the vicinity of 
the selectivity filter/inner turret region of the channels and 3) and lack photo-toxicity .  
 
In coordination with Dr. Kieran Nolan’s group, the scaffold of the dipyrromethane (DPM) 
derivatives, outlined in the Scheme 1, was modelled using the same homology structure of 
Kv1.1 as for the porphyrins. The geometric quality of the backbone conformations and 
energy profiles of the modelled structures fall well within the restrictions established for 
reliable structures (Bowie et al., 1991; Colovos and Yeates, 1993; Laskowski et al., 1996). 
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For refining the side chain of amino acids in the pore region of Kv1.1 channel, flexible 
docking was performed with the Autodock protocol (Morris et al., 2009). The first 
interesting feature revealed was that these molecules have Cdocker energy scores almost 
double that of any of the porphyrin molecules reported previously. DPM I – III gave the 
highest scores of the series evaluated. Modelling showed that the docked molecules interact 
with the outer region of the channel mimicking that of DTXK, a renowned high affinity and 
absolutely specific inhibitor of Kv1.1 (Robertson et al., 1996). This mechanism of binding 
does not possess the same characteristics as 4-aminopyridine but can participate in 
hydrogen bonding and π-π stacking interactions. These advantageous features highlight that 
the dipyrromethane scaffold has promise as the basis for a new lead target molecule.  
 
The predicted interactions of DPM I with the Kv1.1 channel model (Fig. 5.1A) via 
hydrogen bonds (HB) are: Glu353 (two chains); Asp361 (one chain); Tyr375 (one chain); 
Gly376 (one chain); Tyr379 (two chains); Pro 380 (one chain) and Val381 (one chain). 
Hydrophobic contacts include: Met378 (one chain) and Tyr379 (one chain). Similar 
channel interactions were observed with DPM II (Fig. 5.1B) i.e. HB with: Glu353 (one 
chain); Gly374 (all chains); Tyr375 (two chains); Gly376 (two chains); Asp377 (two 
chains); Tyr379 (one chain); Pro 380 (one chain) and Val381 (one chain). Again, 
hydrophobic contacts involved Tyr379 (two chains). Hence, both compounds were 
predicted to contact Glu353 of the outer turret and a range of residues in the inner turret. 
However, the arm of DPM II was expected to be positioned slightly deeper into the inner 
turret (e.g. making contact with Gly374 of all chains) than DPM I.   Predicted interactions 
of DPM III with Kv1.1 channel (Fig. 5.2A) involve HB with: Val373 (two chains) Gly374 
(three chains); Tyr375 (three chains); Gly376 (two chains) Tyr379 (two chains). Note that 
these residues reside in the pore, with pi stacking interactions with Tyr379 of Kv1.1 being 
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important. Guided by the outcomes from these modelling studies, this new generation of 
dipyrromethanes, DPM I – III were prepared with various substitutions, bearing 
alkylammonium side-chains, and screened against recombinantly-generated Kv1 channels 
of known subunit structures.  
 
Scheme 1. Synthetic route employed to prepare the dipyrromethane-based K+ channel inhibitors.  
Three steps were used to build the compounds from the dipyrromethane scaffold 1 (i) DMAP, 
trichloroacetic acid, DCM; (ii) N-boc protected diamine, TEA, DCM room temperature; (iii) 4M 
HCl dioxane, DCM. 
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5.3 Structural characteristics of synthesised and purified DPM I - III  
Their synthesis (Scheme 1) first involved preparing a dipyrromethane scaffold by 
condensation of pyrrole and 4,4-dimethylbenzophenone in the presence of boron 
trifluorodietherate [BF3(OEt)2] to yield compound 1 in 50% yield. Introduction of the 
required carboxyl groups into compound 1 at the 2 position of pyrrole was achieved in 
quantitative yields by electrophilic di-substitution of 1 with trichloroacetic anhydride 
(TClAA) in the presence of a catalyst 4-dimethyl-aminopyridine (DMAP) to generate 
compound 2. The latter was converted to the N-Boc protected precursor 3-5, by stirring 2 
with the appropriate mono N-Boc protected alkyl diamine and TEA at room temperature 
overnight, to give compounds 3-5 in quantitative yield without need for further purification. 
Deprotection of compound 3-5 was achieved using 4M HCl in dioxane to give protonated 
derivatives DPM I – III, in quantitative yields. The identity and purity of DPM I-III were 
confirmed by high-resolution spectrometry and NMR. 
All the synthesis and characterization of above compounds was performed by Dr. Kieran 
Nolan’s group. 
 
5.4 DPM III preferentially inhibits Kv1.1 currents, slows activation and elevates the 
threshold potential 
To measure the reactivity of DPM I-III with Kv1 channels, K+ current generated by those 
containing the major α subunits found in mammalian brain (Shamotienko et al., 1997; 
Coleman et al., 1999) K+ currents were recorded electrophysiologically, using whole-cell 
voltage patch-clamp. Representative K+ current traces, in the absence or presence of 10 µM 
DPM I, revealed some (albeit limited) inhibition of Kv1.1 (Fig. 5.1A) and Kv1.3 (Fig. 
5.1C), with negligible effects on Kv1.2, 1.4 or 1.6 channels (Fig. 5.1C).  Candidate DPM II, 
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which possesses a shorter alkyl chain compared to DPM I, gave much more inhibition of 
Kv1.1 at 10 µM (35 ± 3 %, n = 3) and to a lesser extent for Kv1.3 (16 ± 6 %, n = 3) channels 
whilst being ineffective towards Kv1.2 or 1.6 homomers (Fig. 5.1B, C). Unexpectedly, the 
Kv1.4-mediated current was also considerably reduced by 10 µM DPM II (32 ± 2 %, n = 3) 
(Fig. 5.1C). 
 
Fig. 5.1 A docking model of Kv1.1 channel with two DPMs (I and II) and homomeric Kv1.X channel and 
current traces showing the pharmacological activity of two DPMs.  
Side views of the docking of I (A) and II (B) to the extracellular pore region of Kv1.1 channel. 
Notice that the former interacts with the outer turret region slightly off-centre of the pore, while the 
latter interacts more centrally, protruding deep enough to reach the selectivity filter of Kv1.1. 
Representative electrophysiologically-recorded current traces (lower panels) reveal that DPM I 
produced limited inhibition of Kv1.1 and 1.3 current amplitude with even lower reductions of Kv1.2, 
1.4 and 1.6 currents. More extensive blockade of Kv1.1, 1.4 and 1.3 was caused by DPM II, with 
minimal decreases in Kv1.2 and 1.6. (C) The Kv1.1 channel recordings show greater inhibition by 
DPM II than I. (n = 3-5). 
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The final candidate, DPM III, which has the shortest chain, caused a preferential block (40 
± 3 %, n = 9) of Kv1.1 homomeric channel which could be reversed upon washing (Fig. 
5.2B, D). Its selectivity was highlighted by a lack of effect on Kv1.2, 1.4 or 1.6, though 
some inhibition (~20%) of Kv1.3 was apparent (Fig. 5.2C, D). 
 
 
Fig. 5.2 DPM III showed preferential selectivity for Kv1.1 channel.  
(A) Illustrates modelling of the docking of DPM III with the α subunit of monomeric Kv1.1 
channel. The interacting residues of each α subunits of the channel are represented in orange, red, 
blue and green colors. Notice the interaction of side chains of DPM III with the inner turret lining 
via residues from 4 subunits of Kv1.1 channel; however, the interactions are mainly with two 
subunits. Images were generated using Pymol (De Lano, 2002). (B) Representative current traces 
from Kv1.1 channel in the absence (black) and presence (green) of 10 µM of DPM III showing 
inhibition which was relieved on washing. Currents were evoked at 20 mV voltage steps from -90 
mV holding potential. (C) Recordings demonstrate a lack of effect of 10 µM DPM III on Kv1.2, 1.4 
and 1.6 but some inhibition of Kv1.3. (D) Histogram confirms the preferential inhibition by DPM 
III of Kv1.1 over other channels tested. (n = 3-9). 
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Analysis of different hetero-tetramers of tandem-linked Kv1.1 and 1.2 stably expressed in 
HEK-293 cells yielded varying susceptibilities to the blocker.  
 
 
Fig. 5.3 Concatenated Kv1.1/1.2-containing channels displayed different sensitivities to DPM III.  
(A) Representative current traces from Kv1.1/1.2-containing tetrameric channel in the absence 
(black) and presence (green) of 10 µM DPM III. It partially inhibited channels containing two, 
three or four copies of Kv1.1 subunits, while proving ineffective against Kv1.2 homo-tetramer or 
Kv1.2-1.2-1.1-1.2 channels. (B) Dose-response curves for Kv(1.1)4 (○) and Kv1.1 (■) demonstrate 
similar sensitivity, followed by Kv1.1-1.2-1.1-1.1 (▲) and Kv1.1-1.1-1.2-1.2 (□), while Kv1.2-1.2-
1.1-1.2 (△) and Kv(1.2)4 (●) were non-susceptible. Some of the error bars fall within the data points. 
The IC50 values are summarized in Table 5.1. (C) Summary of equal inhibition by DPM III of 
tetrameric channels containing two copies of Kv1.1 in different positioning within the concatemers. 
(n = 4-8). 
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Decreasing the copy number of Kv1.1 in those concatemers lowered the extent of inhibition 
by 10 µM DPM III (Fig. 5.3A); Kv(1.1)4 > Kv(1.1)31.2 > Kv(1.1)2(1.2)2 with Kv(1.1)(1.2)3 
and Kv(1.2)4 being insensitive. The dose-dependencies for blockade revealed that the IC50 
values decreased from 14 µM for Kv(1.1)4 to 54 and 57 µM upon introducing 1 and 2 
copies of Kv1.2, respectively (Table 5.1). Notably, altering the positions of Kv1.1 and 1.2 
within the concatemers did not influence their blockade by 10 µM DPM III (Fig. 5.3C). 
 
Table 5.1 IC50 values for inhibition by DPM III of Kv1.1 homomer compared to 
various Kv1 concatenated tetramers 
Kv1 channel IC50  
[µM] 
Hill slope n 
Kv1.1 16 ± 1 1.4 ± 0.2 8 
Kv(1.1)4 14 ± 1 1.5 ± 0.2 8 
Kv(1.1)3-1.2 §54 ± 7 1.5 ± 0.1 7 
Kv(1.1)2-(1.2)2 §57 ± 15 1.3 ± 0.2 5 
Kv1.1-(1.2)3 >100 --- 6 
Kv(1.2)4 >100 --- 4 
Results are represented as means ± S.E.M. §values are significant compared to Kv(1.1)4, P < 0.05, 
unpaired Student’s t-test. (n=4-8) 
 
Interestingly, inhibition of Kv1.1 channels by DPM III was associated with significant 
slowing (~10-fold) of activation (Fig. 5.3A, 5.4A). The time constants (τactivation) for 
activation of Kv1.1 currents were slowed from 1.9 (± 0.15 ms, n = 4) to 20.3 (± 3.3 ms, n = 
4), p < 0.005 (Fig. 5.4A) for the homomer and 2.2 (± 0.1 ms, n = 5) to 19.5 (± 3.4 ms, n = 
4), p < 0.001 for the concatemer. Likewise, τactivation values for the heteromeric channels 
were increased by 10 µM DPM III for channels in which the number of Kv1.1 subunits was 
raised to 2 in Kv(1.1)2-(1.2)2 [from 2.8 ± 0.4 ms, n = 6 to 18 ± 2 ms, n = 5] and 3 in 
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Kv(1.1)3-1.2 [from 3.1 ± 0.2 ms, n = 5 to 14 ± 2 ms, n = 5], derived from the representative 
current traces shown (Fig. 5.3A). Moreover, the gk-V relationship of Kv1.1 channel was 
altered by 10 µM DPM III from a half-maximal value for activation (V1/2) of -27 (± 1 mV, 
n = 7) to +11 (± 1 mV, n = 4) (Fig. 5.4B), a significant shift of ~40 mV towards positive 
potentials.  
 
 
Fig. 5.4 The activation kinetics of the K+ current mediated by Kv1.1 channel are slowed by DMP III and 
the threshold potential raised by.  
(A) Time constants of activation (activation) for homomeric Kv1.1 before (empty bar) and after 
application of 10 µM DPM III (filled bar), determined by fitting the current traces with a mono-
exponential function. Notice a significant slowing in the time-course of activation (P < 0.001). (B) 
Conductance-voltage relationship of the steady-state currents calculated from -82 mV reversal 
potential after 200 ms at indicated voltages. Boltzmann fits of the data for homomeric Kv1.1 (○) 
showing a shift towards more positive potentials induced by DPM III (●). Some of the error bars 
fall within the data points. (n = 4-5). 
 
Collectively, these findings unveil notable inhibition by DPM III of Kv1-containing K+ 
channels and compounded modulation of the biophysical properties of Kv1.1. This dual 
action of DPM III in selectively inhibiting K+ currents which would be expected to reduce 
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the hyperpolarization caused by homomeric Kv1.1 and Kv1.1-containing channels such as 
those that are found to be enriched after demyelination of ON axons (Bagchi et al., 2014). 
 
5.5 Discussion 
The pharmacological properties of DPM III, measured electrophysiologically, confirmed 
those predicted from in silico analysis. This compound is devoid of reactivity with Kv1.2, 
1.4 or 1.6 channels, and preferentially inhibits Kv1.1 over 1.3 channels. Evaluation of this 
promising molecule on Kv1.1/1.2-heteromeric channels was possible by utilizing a cloning 
platform that afforded expression of four α subunits as single-chain proteins on the 
plasmalemma, with the stochiometry and positions of their subunits pre-determined (Al-
Sabi et al., 2010; also see Chapter 4). Tetrameric combinations that should correspond to 
those predicted to occur in brain (Shamotienko et al., 1997; Coleman et al., 1999) were 
selected for investigation, including those Kv1.1-enriched channels observed in 
demyelinated axons (Bagchi et al., 2014). Selectivity and potency of DPM III inhibiting 
Kv1.1 channel arises from acting extracellularly, in large part, with the inner turret regions 
of Kv1.1 before occluding the channel deep in its vestibule. Its limited cross reactivity with 
Kv1.3, may be due to the latter’s accessible serines closely resembling those lining the 
turret of Kv1.1 (Daly et al., 2015). On the other hand, Kv1.1 and 1.2 channels share similar 
susceptibility to 4-AP due to their conserved inner vestibule region where this molecule 
interacts (Stuhmer et al., 1989; McCormack et al., 1991). The selective inhibition and 
slowing of activation kinetics of the Kv1.1 channel highlights the dual advantages of DPM 
III. Bagchi et al. (2014) demonstrated that in demyelinated axons of mouse ON an increase 
in ectopic expression of Kv1.1 subunit contributes to abnormal compound APs (CAPs). 
These K+ channels decrease the voltage threshold (i.e. they activate at more negative 
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potentials) and accelerate the activation kinetics, thereby, perturb the axonal propagation of 
electrical signals. It was found that this dysfunction can be partially overcome by the Kv1.1-
selective inhibitor, DTXK (Bagchi et al. 2014). Although such an avid toxin cannot be 
considered as a potential neurotherapeutic, its beneficial effects observed in vitro warrant 
the development of more suitable smaller inhibitors. It is encouraging that DPM III offers a 
double advantage in preferentially inhibiting Kv1.1-dependent currents, including slowing 
their activation and shifting the conductance-voltage relationship of Kv1.1 to more positive 
potentials. Such a beneficial modulatory action could further help normalize the CAPs in 
demyelinated axons, a discovery of relevance to patho-physiology of MS. Its effect on the 
activation kinetics could be explained by interaction deep in the pore region of Kv1.1 
channels. Furthermore, DPM III is impermeable to intact cell membranes and can 
distinguish between Kv1.1 and the much more prevalent 1.2 channels. In contrast, the 
internal blocker, 4-AP, is readily membrane permeable, interacts with both Kv1.1 and 1.2 
channels with similar potency and can cross the blood-brain barrier. 
 
Unlike 4-AP, DPM III was found to be a more specific and potent blocker of recombinant 
Kv1.1, and devoid of effect on Kv1.2. In this regard, evidence exists for the involvement of 
Kv1.2 in peripheral nerve hyper-excitability in patients suffering from type II diabetes or 
amyotrophic lateral sclerosis (Shibuya et al., 2011, Zenker et al., 2012), an undesirable 
situation that could possibly be avoided by using DPM III. As the inflammatory 
component in MS pathophysiology is of prime importance, the noted inhibition of Kv1.3 by 
DPM III might have an additional beneficial effect because this channel is known to 
activate T cells and is highly expressed on the inflammatory infiltrates in MS; moreover, 
Kv1.3 is a functional marker of activated effector memory T cells in experimental allergic 
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encephalomyelitis and in myelin-specific T cells derived from the peripheral blood of MS 
patients. So DPM III not only presents potential therapeutic properties that could be useful 
to restore conduction in demyelinated fibers but might also modulate the inflammatory 
events which occur in MS. 
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CHAPTER 6 
 
GENERAL DISCUSSION 
 
The key experimental observations of this research were discussed in the respective 
chapters covering the different objectives (see Section 1.12). 
 
The focus on characterization of neuronal K+ channels, particularly Kvs, is ongoing work in 
Prof. Dolly’s lab since the identification of voltage-sensitive K+ (Kv1) channel proteins 
isolated using α DTX (Dolly et al., 1984; Mehraban et al., 1984). This polypeptide from the 
green mamba Dendroaspis angusticeps, had been shown by electrophysiological recording 
to selectively inhibit A-type K+ currents (Halliwell et al., 1986) or slow inactivating 
variants (Stansfeld et al., 1987). Complementary genetic approaches revealed that 
mammalian Kv channels consist of four α subunits forming a central pore as tetramers, each 
containing six transmembrane α-helical segments S1–S6 and a membrane-reentering P-loop 
(P), which are arranged circumferentially around the central pore region as see in Fig. 6.1 
(Tempel et al., 1987; Kamb et al., 1988; Pongs et al., 1988; MacKinnon, 1991). Four 
subunits are assembled, probably in the endoplasmic reticulum and targeted to the plasma 
membrane to form a functional channel, with both their N- and C-termini in the cytoplasm. 
Many studies have been performed on the monomeric channels which were assumed to 
have formed functional tetramers. However, such investigations on these channels are still 
considered limited; re-creating a channel with four individual α-subunit genes to form a 
single protein would be very advantageous for assessing their properties in order to mimic 
107 
 
the native neuronal Kv1 homo- and hetero-tetrameric channels observed in brain 
(Shamotienko et al., 1997; Coleman et al., 1999). Thus, the present work reported an 
improved method for gaining insights into the functional and biophysical characteristics of 
Kv1 channels, using a concatenated strategy that has been developed in our Centre (Dolly 
and Shamotineko, Patent, 2011).  
 
 
Fig. 6.1 Neuronal Kv1 are (α)4(β)4 proteins - complete structures solved. (A) Membrane 
topography of Kv1 α and β subunits. Membrane topography shows that Kv1 channels contain 6-TM 
and 1-P domain, which has a cytoplasmic N and C-terminal associated with β-subunit. (adapted 
from Scott et al., 1994). (B, C) 3D structure of brain Kv1 channels (adapted from Orlova et al., 
2003) and X-ray structure of a Kv(1.2)4 (β2)4 (adapted from Long et al., 2005), respectively, 
revealed the assembly of 4 α and 4 β subunits. (D) Predicted arrangement of α subunits. Various 
subtypes of Kv1 α subunits occur in neurons, which can possibly form homomers and heteromers. 
 
Development and use of concatenation for mimicking the possible Kv1 subunit 
combinations of neuronal tetrameric channels 
Previous studies used co-expression of different ratios of various Kv channel monomeric 
subunits or concatenated dimers in the hope of obtaining functional channels. Though they 
succeeded in producing linked tetramers (Heginbotham and MacKinnon, 1992; Hurst et al., 
1992; Kavanaugh et al., 1992; Liman et al., 1992), it proved cumbersome to demonstrate 
that uniform populations of heteromeric channels were expressed in the plasmalemma. 
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Using our much better strategy, concatenated tetramers composed of Kv1.1, 1.2, 1.4 and 1.6 
α subunits representative of their neuronal counterparts were obtained, using versatile 
methodology for generating constructs encoding controlled combinations and spatial 
arrangements of subunits; these resulted in multimeric tetrameric proteins after expression 
in mammalian cells. Unique restriction sites were identified where enzymes do not cut 
within the actual genes of interest but allow cloning of subunit genes into cassettes at pre-
selected positions. This requires careful design of concatenated constructs that are 
physically connected by linkers of the appropriate size; otherwise, adverse effects could 
arise in terms of alterations in the conformational states of some subunits (McCormack et 
al., 1992).  Also, the sequences chosen must be devoid of selected unique restriction sites. 
This was facilitated by a half-linker strategy which we invented to join appropriately-
selected pairs of restriction enzyme sites NheI/BglII, BglII/EcoRI, EcoRI/SalI and 
SalI/BamHI (see Sections 2.3.1 and 2.3.3, Chapter 2). Such a process is accomplished by a 
single PCR, using specific primers for 4 pairs of enzymes and the 2 halves of the link on 
either sides of the gene. This novel concept permitted the simultaneous and easy creation of 
a bank of intermediate cassettes, which were utilized to produce a large number of hetero-
tetramers. Advantageously, the concept of having position-specific enzyme sites with half-
linkers permits the insertion of any particular gene into a given position. Likewise, the ease 
of the whole process involving few steps minimizes errors, time and cost which made it 
much more advantageous than the concatenation methods attempted by others (Liman et 
al., 1992; Akhtar et al, 2002).  
 
Restriction enzyme digestion and DNA sequencing of extracted DNA from E. coli 
transformed with the concatenated genes established that the tetramers had the correct 
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integrity and composition. There was no indication of a position-dependent over-
representation of any subunit or channels that assembled with distorted symmetry, 
problems noted with Kv1 concatemers made by a less stringent method and expressed in 
Xenopus oocytes (McCormack et al., 1992; Hurst et al., 1995).  
 
Pre-defined arrangement of concatenated α subunits was confirmed by the observed 
abolishment of Kv1.4 NIB function when placed adjacent to the NIP domain of Kv1.6 
Hetero-polymerization has been reported to occur only among members of the same 
subfamily of Kv channels (Covarrubias et al. 1991; Salkoff et al., 1992). Heteromeric 
channels using Kv1.4, 1.6, 1.2 or 1.1 have been localized in several structures within the 
nervous system (Wang et al., 1993, 1994; Scott et al., 1994a; Shamotienko et al., 1997; 
D’Adamo et al., 1999). However, the relative order of subunits within the channel may be 
different. The reliability of our concatenation in expressing functional tetrameric channel 
with pre-defined positioning of α subunits, was verified by producing different types of 
inactivation profiles, exploiting the functionalities of NIB and NIP domains present in 
Kv1.4 and 1.6, respectively (Hoshi et al., 1990; Zagotta et al., 1990; Tseng-Crank et al., 
1990). After transfecting HEK-293 cells with genes encoding various α subunits (Kv1.4-, 
1.6- and 1.2-α subunits), having distinct pharmacological and/or biophysical characteristics, 
the resultant concatenated tetramers exhibited the expected findings without evidence of 
any proteolysis of linked subunits possible during their expression (Baumann, et al., 2003) 
and, also, one can expect that large constructs may exhibit decreased expression and 
reduced delivery to the cell surface membrane (Ji et al., 2008). Such difficulties were 
circumvented as our cell surface biotinylation and Western blotting experiments confirmed 
the plasmalemmal expression of intact tetrameric channel without evidence of any 
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proteolysis (see Section 3.3, Chapter 3), which was not performed by others previously 
(McCormack et al., 1992; Hurst et al., 1995). The system validated in the present study for 
creating heteromers which exhibit fast inactivation provided scope for evaluating a 
biochemical basis for their distinct biophysical properties. Placing Kv1.4 and 1.6 subunits 
distant in hetero-tetramers (Kv1.4–1.2–1.6–1.2 and Kv1.4–1.2–1.2–1.2) gave fast-
inactivating channels. When they were placed in adjacent positions (Kv1.4–1.6–1.2–1.2 and 
Kv1.4–1.2–1.2–1.6) the channels showed slow inactivation with variable τ1inact but not τ2inact 
values. Moreover, significant shift in V1/2 of the Kv1.4–1.6–1.2–1.2 and Kv1.4–1.2–1.2–1.6 
channels towards more depolarized potentials correlates with the slow inactivation due to 
predicted adjacent positioning of the NIP to NIB, contrasting with that for the fast-
inactivating Kv1.4–1.2–1.6–1.2 channels. Kv1 channels with mutations in the NIP domain 
of Kv1.6 (Kv1.4–1.2–1.6(E27/30/32A)–1.2) and (Kv1.4–1.6(E27/30/32A)–1.2–1.2) showed 
inactivation profiles similar to Kv1.4–1.2–1.6–1.2, suggesting NIP domain in Kv1.6 
prevents fast inactivation and also highlights that presence of a mutant subunit did not 
affect the concatenation and function of the tetramer. 
 
Role of subunit stoichiometry and positioning in determining the biophysical and 
pharmacological properties of Kv1.1/1.2-containing tetrameric channels 
Kv1.2 has been found to be the predominant isoform in αDTX-sensitive acceptors from 
several regions of mammalian brain (Scott et al., 1994a). However, the function of a 
particular K+ channel subunit cannot be dictated only by its subcellular location, but also by 
the other subunit types with which it combines. For example, Kv1.1 prevents the axonal 
localization of Kv1.4-complexed channels, but not Kv1.2-containing heteromultimers 
(Jenkins et al., 2011). Both Kv1.1 and 1.2 were localized at juxta-paranodal regions of 
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myelinated axons and synaptic terminals in mouse (Wang et al., 1993 and 1994) and rat 
brain (McNamara et al, 1993 and 1996; Sheng et al., 1994; Wang et al., 1999). This 
localization suggests that both the channels may influence AP propagation, repolarization, 
and conduction as well as regulate neurotransmittter release. Though both are of same 
subfamily and co-express at identical subcellular locations and have similar implications in 
epilepsy and ataxia, loss of function of one or other exhibits a difference in seizure 
phenotypes (Robbins and Tempel, 2012). Likewise, their pharmacological profiles are 
distinct; Kv1.1 channel is sensitive to TEA and 1.2 insensitive (MacKinnon and Yellen, 
1990; Kavanaugh et al., 1991). Since they are abundantly co-localized, it becomes 
important to know how they act when they form hetero-tetramers with different 
stoichiometry and positioning. Co-expression studies indicated that stoichiometry is the key 
component that influences the susceptibility to TEA (Hurst et al., 1992; Shen et al., 1994), 
but did not address the influence of positioning, due to lack of an ideal concatenation 
strategy. Though earlier published data suggests that TEA sensitivity of adjacently- and 
diagonally-positioned Kv1.1 and 1.2 subunits in Kv1 channels is different when using equal 
copies of both subunits (Al-Sabi et al., 2010), the data herein establishes that both 
stoichiometry and positioning affects TEA binding to sensitive Kv1 subunits in 
concatenated tetramers. Homo-tetrameric Kv1.1 and 1.2 channels both yielded a IK current 
with the most negative V1/2 value and most positive V1/2 value, respectively, similar to their 
non-concatenated counterparts; this indicates that concatenation does not affect the 
biophysical characteristics. With increase in the number of identical subunits in Kv1.1/1.2 
hetero-tetramers the V1/2 values shifted towards their homomeric channels, showing the 
direct influence of subunit stoichiometry on their biophysical criteria. In addition, replacing 
one of Kv1.1 subunit with an insensitive Kv1.2 constituent to produce Kv1.1-1.2-1.1-1.1, 
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made the channel significantly less sensitive than Kv1.1 homo-tetramer. Raising the ratio of 
Kv1.2 to Kv1.1 in Kv1.1-1.1-1.1-1.1 reduced the sensitivity of the tetrameric channel to 
TEA proving that the number of insensitive subunits affects TEA binding. 
 
Mutations of the pore region of Kv1.2 in tetrameric Kv1.1/1.2-containing channels that 
increases TEA binding 
Due to the lack of TEA sensitivity related to Kv1.2 channels some critical amino acid 
residues were examined. When the key amino acid valine 381 in the pore region of Kv1.2 
channel was mutated to tyrosine (Kv1.2(V381Y)), the TEA binding increased greatly. Also, 
similar sensitivity was recorded with a double mutation Kv1.2(R354A/V381Y) of non-
concatenated homomer; however, these values still differ significantly from that for Kv1.1 
homomer. Concatenated tetramer with pore mutation (Kv1.2(V381Y)-1.2-1.1-1.1) behaved 
similarly as Kv1.1-1.2-1.1-1.1 channel and proved ~10 times more TEA sensitive compared 
to its previously reported wild-type (Table 4.3, Al-Sabi et al., 2010). This showed that the 
Kv1.2(V381Y) subunit in this tetramer is behaving similarly to Kv1.1. In contrast, the channel 
possessing one more Kv1.2 subunit (Kv1.2(V381Y)-1.2-1.1-1.2) did not behave close to Kv1.1-
1.2-1.1-1.2, but displayed sensitivity similar to Kv1.2-1.2-1.1-1.2. Using the same 
stoichiometry but with positioning Kv1.1 adjacent to mutated subunit (Kv1.2(V381Y)-1.2-1.2-
1.1) made the channel significantly sensitive to TEA, similar to that of  Kv1.2-1.2-1.1-1.1. 
It is notable that increasing one insensitive copy of Kv1.2 in Kv1.2(V381Y)-1.2-1.1-1.1 did 
yield different sensitivity than expected, and further changing the position of Kv1.1 with 
same stoichiometry showed a 10-fold difference between their sensitivities. Overall, our 
results showed that both stoichiometry and positioning influence the biophysical and 
pharmacological properties of Kv1.1/1.2-containing channels. Since the mutation in turret 
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region of Kv1.2 is behaving close to that of Kv1.1 raising sensitivity to TEA, Kv1.1 is an 
ideal target for blockers or inhibitors. As TEA and 4-AP are considered as non-selective 
blockers (Lin et al., 1993), used in millimolar range which could cause severe toxicity in 
clinical applications, it is desirable to develop a new selective blocker for Kv1.1, which is a 
prime target in treating MS (Judge and Bever Jr., 2006). 
 
Development and screening of Kv1 channel selective blockers (dipyromethane 
compounds) using monomeric and concatenated tetrameric Kv1.X channels 
Recent findings from our lab demonstrated that Kv1.1-containing channels are expressed 
ectopically and contribute to abnormal CAP in demyelinated axons from ON of m i c e  
f e d  with cuprizone (Bagchi et al., 2014). In collaboration with a group led by Dr. Kieran 
Nolan in Chemistry Department, DCU, we utilized the monomeric and concatenated Kv1 
channels subunits as representative targets for the development of new, small and selective 
inhibitors of Kv1.1. The observations from the experimental data to date look promising; 
out of three compounds (DPM I – III) tested, DPM III was found to be selective and 
effective as a blocker of Kv1.1 in micromolar range. Selectivity of DPM III, a 
dipyrromethane molecule bearing two C2-alkylammonium side chains, is assumed to be 
achieved mainly by interaction with residue Tyr379 in the inner turret region of Kv1.1, 
distinct from 4-AP, which interacts with conserved inner vestibule region similar in Kv1.1 
and 1.2 channels (Stuhmer et al., 1989; McCormack et al., 1991). Molecular modelling 
studies revealed that DPM III binds to the outer region of the Kv1.1 channel while inserting 
its reactive groups into the channel pore, mimicking the action of DTXK (Stansfeld et al., 
1987). This limits its cross reactivity with Kv1.3, which has similar residues lining the turret 
region of Kv1.1), while discriminating other Kv1 channels (Kv1.2, 1.4 and 1.6). Highly 
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significant inhibition of Kv1.1 channel by 10 µM DPM III compared to Kv1.2, 1.4 and 1.6, 
proves the potency and selectivity of DPM III for Kv1.1.  
  
Kv1.1/1.2-containing channels were used to assess the activity of DPM III on concatenated 
heteromeric channels. The dose-dependencies for blockade revealed that the IC50 of 
concatenated Kv(1.1)4 is 14 µM.  Substituting the copy number of Kv1.1 with 1.2 in the 
concatemers reduced the percentage of inhibition by 10 µM DPM III, as channels become 
insensitive. Though the stoichiometry of Kv1.1 to 1.2 influenced the blocking of 
heteromeric channels by DPM III, the change in the Kv1.1 subunit positioning within the 
concatemers did not influence their blockade DPM III. Since the Kv1.2 mutation in turret 
region, as stated above, affected the binding of TEA for Kv1.1/1.2-containing channels with 
difference in stoichiometry and positioning of wild-type Kv1.1, similarly, it is interesting to 
find the effect of DPM III on Kv1.1 and 1.2 tetramers containing mutated Kv1.2. 
 
Future directions 
More research is still needed before we can understand how exactly the Kv1 channels 
behave in an octomeric complex (with both α and β subunits) in mammalian cells and 
cultured neurons. Coleman et al. was the first to report the α-subunit composition of 
(α)4(β)4 oligomers and their association with β-subunits in human CNS, using cerebral grey 
and white matter, plus spinal cord from autopsy samples. Sequential immuno-precipitation 
identified the abundance of Kv1.1, 1.2, and 1.4 in all the tissues (Coleman et al., 1999). 
Future co-expression of concatenated pre-defined individual α and β subunit homo- and 
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hetero-tetramers, could give more valuable information on the function of the individual 
subunit and thereby, further elucidate the complexity.  
 
With availability of the successful expression system in mammalian cells and fully defined 
cloned Kv1 genes, it would be advantageous to proceed to validate the characteristics of 
recombinant Kv1 channels by expressing them in cultured neurons. To assess the validity of 
the biophysical and pharmacological characteristics obtained in HEK-293 cells it seems 
highly desirable to express Kv1 in neurons so covalent modifications would be more 
authentic provided a developmental stage can be selected before expression of endogenous 
channels. This could be attempted in hippocampal neurons. Little or no expression of Kv1 
channels have been reported for hippocampus at an embryonic stage of Wistar rat (Ficker 
and Heinemann, 1992), Spargue-dawley rat (Maletic-Savatic et al., 1995) and mouse 
(Grosse et al., 2000, Sánchez-Ponce et al., 2012). Preliminary experiments in our hands 
showed that cultured neurons from embryonic18 (E18) hippocampus of Spargue-dawley 
rats did not express Kv1.1 and 1.2 channels in day 7 cultures in vitro. Search for the 
existence of other Kv channels is being continued. Hence, selection of early stage 
hippocampal culture (within 7 days in vitro) as an ideal platform for viral expression of 
monomeric and tetrameric Kv1.X channels in neuronal cells, followed by confirmation of 
their expression using biochemical methods; allows determination of their biophysical and 
pharmacological properties electrophysiologically. Since other proteins such as CAMs and 
MAGUKs associate with Kv1 channels in neurons (Ogawa et al., 2008), it is expected that 
these channels will behave differently, both in biochemical and biophysical terms than 
those HEK-293 cells. Such new information could provide a more reliable basis for 
molecular modeling and design of specific inhibitors as drugs (see Chapter 4). Also, further 
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studies involving co-expression of recombinant β subunits (β1.1 or β2.1) with Kv1.1 or 1.2 
in the hippocampal neuronal platform, mimicking the native K+ channel expression, and 
assessing their membrane distribution, biophysical and pharmacological properties, should 
provide more functional data to foster a deeper understanding of the control of neuronal 
excitability. 
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